Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Rainer Storb

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Living Beings

Chemicals & Drugs

Physiology

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ding Yunchuan; Rotta Marcello; Graves Scott S; Storer Barry E; Peterson Laura J; Sale George E; Forough Reza; Zellmer Eustacia; Georges George E; Sandmaier Brenda M; Kuhr Christian S; Storb Rainer
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.
Graves Scott S; Stone Diane; Loretz Carol; Peterson Laura; McCune Jeannine S; Mielcarek Marco; Storb Rainer
Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.
Schiffer Joshua T; Kirby Kate; Sandmaier Brenda; Storb Rainer; Corey Lawrence; Boeckh Michael
Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Rainer Storb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ding Yunchuan; Rotta Marcello; Graves Scott S; Storer Barry E; Peterson Laura J; Sale George E; Forough Reza; Zellmer Eustacia; Georges George E; Sandmaier Brenda M; Kuhr Christian S; Storb Rainer
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1244-50.
2009: Graves Scott S; Stone Diane; Loretz Carol; Peterson Laura; McCune Jeannine S; Mielcarek Marco; Storb Rainer
Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.
Transplantation 2009;88(3):317-22.
2009: Schiffer Joshua T; Kirby Kate; Sandmaier Brenda; Storb Rainer; Corey Lawrence; Boeckh Michael
Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.
Haematologica 2009;94(8):1101-8.
2009: Nishida Tetsuya; Hudecek Michael; Kostic Ana; Bleakley Marie; Warren Edus H; Maloney David; Storb Rainer; Riddell Stanley R
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4759-68.
2009: Storb Rainer
Reduced-intensity conditioning transplantation in myeloid malignancies.
Current opinion in oncology 2009;21 Suppl 1():S3-5.
2009: Carnevale-Schianca Fabrizio; Leisenring Wendy; Martin Paul J; Furlong Terry; Schoch Gary; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Kiem Hans-Peter; Storb Rainer; McDonald George B; Nash Richard A
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):749-56.
2009: Nakamae Hirohisa; Kirby Katharine A; Sandmaier Brenda M; Norasetthada Lalita; Maloney David G; Maris Michael B; Davis Chris; Corey Lawrence; Storb Rainer; Boeckh Michael
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):694-703.
2009: Baron Frédéric; Petersdorf Effie W; Gooley Ted; Sandmaier Brenda M; Malkki Mari; Chauncey Thomas R; Maloney David G; Storb Rainer
What is the role for donor natural killer cells after nonmyeloablative conditioning?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):580-8.
2009: Bruno Benedetto; Rotta Marcello; Patriarca Francesca; Mattei Daniele; Allione Bernardino; Carnevale-Schianca Fabrizio; Sorasio Roberto; Rambaldi Alessandro; Casini Marco; Parma Matteo; Bavaro Pasqua; Onida Francesco; Busca Alessandro; Castagna Luca; Benedetti Edoardo; Iori Anna Paola; Giaccone Luisa; Palumbo Antonio; Corradini Paolo; Fanin Renato; Maloney David; Storb Rainer; Baldi Ileana; Ricardi Umberto; Boccadoro Mario
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo.
Blood 2009;113(14):3375-82.
2009: Nakamae Hirohisa; Wilbur D Scott; Hamlin Donald K; Thakar Monica S; Santos Erlinda B; Fisher Darrell R; Kenoyer Aimee L; Pagel John M; Press Oliver W; Storb Rainer; Sandmaier Brenda M
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
Cancer research 2009;69(6):2408-15.
2009: Mielcarek Marco; Storer Barry E; Boeckh Michael; Carpenter Paul A; McDonald George B; Deeg H Joachim; Nash Richard A; Flowers Mary E D; Doney Kristine; Lee Stephanie; Marr Kieren A; Furlong Terry; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Blood 2009;113(13):2888-94.
2009: Storb Rainer
B cells versus T cells as primary barrier to hematopoietic engraftment in allosensitized recipients.
Blood 2009;113(5):1205.
2009: Wang Zejing; Chamberlain Jeffrey S; Tapscott Stephen J; Storb Rainer
Gene therapy in large animal models of muscular dystrophy.
ILAR journal / National Research Council, Institute of Laboratory Animal Resources 2009;50(2):187-98.
2008: Burroughs Lauri M; O'Donnell Paul V; Sandmaier Brenda M; Storer Barry E; Luznik Leo; Symons Heather J; Jones Richard J; Ambinder Richard F; Maris Michael B; Blume Karl G; Niederwieser Dietger W; Bruno Benedetto; Maziarz Richard T; Pulsipher Michael A; Petersen Finn B; Storb Rainer; Fuchs Ephraim J; Maloney David G
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1279-87.
2008: Graves Scott S; Hogan William J; Kuhr Christian; Diaconescu Razvan; Harkey Michael; Sale George E; Stone Brad; Georges George E; Storb Rainer
Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1201-8.
2008: Sorror Mohamed L; Storer Barry E; Sandmaier Brenda M; Maris Michael; Shizuru Judith; Maziarz Richard; Agura Edward; Chauncey Thomas R; Pulsipher Michael A; McSweeney Peter A; Wade James C; Bruno Benedetto; Langston Amelia; Radich Jerald; Niederwieser Dietger; Blume Karl G; Storb Rainer; Maloney David G
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
2008: Woolfrey Ann E; Malhotra Uma; Harrington Robert D; McNevin John; Manley Thomas J; Riddell Stanley R; Coombs Robert W; Appelbaum Frederick R; Corey Larry; Storb Rainer
Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.
Blood 2008;112(8):3484-7.
2008: Scott Bart L; Park J Y; Deeg H Joachim; Marr Kieren A; Boeckh Michael; Chauncey Thomas R; Appelbaum Frederick R; Storb Rainer; Storer Barry E
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):799-806.
2008: Parker Maura H; Kuhr Christian; Tapscott Stephen J; Storb Rainer
Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(7):1340-6.
2008: Jochum Christoph; Beste Mechthild; Stone Diane; Graves Scott S; Storb Rainer
Development and in vitro characterization of canine CD40-Ig.
Veterinary immunology and immunopathology 2008;123(3-4):260-5.
2008: Furlong Terry; Kiem Hans-Peter; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Flowers Mary E D; Mielcarek Marco; Nash Richard A; Storb Rainer; Martin Paul J
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):531-7.
2008: Sorror Mohamed; Storer Barry; Sandmaier Brenda M; Maloney David G; Chauncey Thomas R; Langston Amelia; Maziarz Richard T; Pulsipher Michael; McSweeney Peter A; Storb Rainer
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 2008;112(9):1992-2001.
2008: Sala-Torra O; Martin P J; Storer B; Traina F; Sorror M L; Storb R; Sandmaier B M; Flowers M E D
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens.
Bone marrow transplantation 2008;41(10):887-93.
2008: Sorror Mohamed L; Leisenring Wendy; Mielcarek Marco; Baron Frederic; Diaconescu Razvan; Hogan William J; Graves Scott S; Storb Rainer
Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
Transplantation 2008;85(7):1023-9.
2008: Parikh Chirag R; Yarlagadda Sri G; Storer Barry; Sorror Mohamed; Storb Rainer; Sandmaier Brenda
Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(3):309-15.
2008: Rezvani Andrew R; Storb Rainer
Using allogeneic stem cell/T-cell grafts to cure hematologic malignancies.
Expert opinion on biological therapy 2008;8(2):161-79.
2008: Lupu M; Gooley T; Zellmer E; Graves S S; Storb R
Principles of peripheral blood mononuclear cell apheresis in a preclinical canine model of hematopoietic cell transplantation.
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2008;22(1):74-82.
2008: Mattsson Jonas; Ringdén Olle; Storb Rainer
Graft failure after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1 Suppl 1):165-70.
2008: Rezvani Andrew R; Storer Barry; Maris Michael; Sorror Mohamed L; Agura Edward; Maziarz Richard T; Wade James C; Chauncey Thomas; Forman Stephen J; Lange Thoralf; Shizuru Judith; Langston Amelia; Pulsipher Michael A; Sandmaier Brenda M; Storb Rainer; Maloney David G
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
2008: Sorror Mohamed L; Storer Barry E; Maloney David G; Sandmaier Brenda M; Martin Paul J; Storb Rainer
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
Blood 2008;111(1):446-52.
2007: Mielcarek Marco; Storer Barry E; Sandmaier Brenda M; Sorror Mohamed L; Maloney David G; Petersdorf Effie; Martin Paul J; Storb Rainer
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1499-507.
2007: Bonfim Carmem M; de Medeiros Carlos R; Bitencourt Marco A; Zanis-Neto José; Funke Vaneuza A M; Setubal Daniela C; Ruiz Jefferson; Sanders Jean E; Flowers Mary E D; Kiem Hans-Peter; Storb Rainer; Pasquini Ricardo
HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1455-60.
2007: Sorror Mohamed L; Giralt Sergio; Sandmaier Brenda M; De Lima Marcos; Shahjahan Munir; Maloney David G; Deeg H Joachim; Appelbaum Frederick R; Storer Barry; Storb Rainer
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
2007: Mielcarek Marco; Storer Barry E; Flowers Mary E D; Storb Rainer; Sandmaier Brenda M; Martin Paul J
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1160-8.
2007: Burroughs L M; Storb R; Leisenring W M; Pulsipher M A; Loken M R; Torgerson T R; Ochs H D; Woolfrey A E
Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders.
Bone marrow transplantation 2007;40(7):633-42.
2007: Kahl Christoph; Storer Barry E; Sandmaier Brenda M; Mielcarek Marco; Maris Michael B; Blume Karl G; Niederwieser Dietger; Chauncey Thomas R; Forman Stephen J; Agura Edward; Leis Jose F; Bruno Benedetto; Langston Amelia; Pulsipher Michael A; McSweeney Peter A; Wade James C; Epner Elliot; Bo Petersen Finn; Bethge Wolfgang A; Maloney David G; Storb Rainer
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2007;110(7):2744-8.
2007: Sorror Mohamed L; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Baron Frédéric; Maloney David G; Scott Bart L; Deeg H Joachim; Appelbaum Frederick R; Storb Rainer
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
2007: Baron Frédéric; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Langston Amelia A; Lange Thoralf; Petersdorf Effie; Bethge Wolfgang; Maziarz Richard T; McSweeney Peter A; Pulsipher Michael A; Wade James C; Chauncey Thomas R; Shizuru Judith A; Sorror Mohamed L; Woolfrey Ann E; Maloney David G; Storb Rainer
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
2007: Kuhr Christian S; Yunusov Murad; Sale George; Loretz Carol; Storb Rainer
Long-term tolerance to kidney allografts in a preclinical canine model.
Transplantation 2007;84(4):545-7.
2007: Kuhr Christian S; Lupu Marilena; Storb Rainer
Hematopoietic cell transplantation directly into dystrophic muscle fails to reconstitute satellite cells and myofibers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(8):886-8.
2007: Chang Chunkang; Storer Barry E; Scott Bart L; Bryant Eileen M; Shulman Howard M; Flowers Mary E; Sandmaier Brenda M; Witherspoon Robert P; Nash Richard A; Sanders Jean E; Bedalov Antonio; Hansen John A; Clurman Bruce E; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.
Blood 2007;110(4):1379-87.
2007: Nash Richard A; McSweeney Peter A; Crofford Leslie J; Abidi Muneer; Chen Chien-Shing; Godwin J David; Gooley Theodore A; Holmberg Leona; Henstorf Gretchen; LeMaistre C Fred; Mayes Maureen D; McDonagh Kevin T; McLaughlin Bernadette; Molitor Jerry A; Nelson J Lee; Shulman Howard; Storb Rainer; Viganego Federico; Wener Mark H; Seibold James R; Sullivan Keith M; Furst Daniel E
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
Blood 2007;110(4):1388-96.
2007: Venkataraman G M; Stroup P; Graves S S; Storb R
An improved method for dog leukocyte antigen 88 typing and two new major histocompatibility complex class I alleles, DLA-88*01101 and DLA-88*01201.
Tissue antigens 2007;70(1):53-7.
2007: Graves Scott S; Hogan William; Kuhr Christian S; Diaconescu Razvan; Harkey Michael A; Georges George E; Sale George E; Zellmer Eustacia; Baran Szczepan; Jochum Christoph; Stone Brad; Storb Rainer
Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
Blood 2007;110(1):418-23.
2007: Yunusov Murad Y; Kerbauy Fabio; Abrams Kraig; Zellmer Eustacia; Spector Michele; Kuhr Christian S; Hwang Billanna; Storer Barry; Georges George E; Weigler Benjamin J; Storb Rainer; Nash Richard A
Intussusception in canine recipients of hematopoietic cell grafts and surgical correction.
Comparative medicine 2007;57(3):287-91.
2007: Wang Zejing; Kuhr Christian S; Allen James M; Blankinship Michael; Gregorevic Paul; Chamberlain Jeffrey S; Tapscott Stephen J; Storb Rainer
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(6):1160-6.
2007: Georges George E; Maris Michael B; Maloney David G; Sandmaier Brenda M; Sorror Mohamed L; Shizuru Judith A; Lange Thoralf; Agura Edward D; Bruno Benedetto; McSweeney Peter A; Pulsipher Michael A; Chauncey Thomas R; Mielcarek Marco; Storer Barry E; Storb Rainer
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):423-32.
2007: Lupu M; Storb R
Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.
Veterinary and comparative oncology 2007;5(1):14-30.
2007: Bruno Benedetto; Rotta Marcello; Patriarca Francesca; Mordini Nicola; Allione Bernardino; Carnevale-Schianca Fabrizio; Giaccone Luisa; Sorasio Roberto; Omedè Paola; Baldi Ileana; Bringhen Sara; Massaia Massimo; Aglietta Massimo; Levis Alessandro; Gallamini Andrea; Fanin Renato; Palumbo Antonio; Storb Rainer; Ciccone Giovannino; Boccadoro Mario
A comparison of allografting with autografting for newly diagnosed myeloma.
The New England journal of medicine 2007;356(11):1110-20.
2007: Storb Rainer
Can reduced-intensity allogeneic transplantation cure older adults with AML?
Best practice & research. Clinical haematology 2007;20(1):85-90.
2007: Kerbauy Daniella M B; Gooley Theodore A; Sale George E; Flowers Mary E D; Doney Kristine C; Georges George E; Greene Joanne E; Linenberger Michael; Petersdorf Effie; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed; Stirewalt Derek L; Stewart F Marc; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):355-65.
2007: Baron Frédéric; Storb Rainer
Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission.
Current opinion in hematology 2007;14(2):145-51.
2007: Jochum Christoph; Beste Mechthild; Zellmer Eustacia; Graves Scott S; Storb Rainer
CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(2):164-71.
2007: Wang Zejing; Allen James M; Riddell Stanley R; Gregorevic Paul; Storb Rainer; Tapscott Stephen J; Chamberlain Jeffrey S; Kuhr Christian S
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy.
Human gene therapy 2007;18(1):18-26.
2006: Lupu Marilena; McCune Jeannine S; Kuhr Christian S; Gooley Theodore; Storb Rainer
Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1352-4.
2006: Graves Scott S; Ryoo Hun-Mo; Sale George; Storb Rainer; Cowan Laine A; Matsuda Katherine
Pegylated TNF-alpha receptor does not prevent acute graft-versus-host disease in the dog leukocyte antigen-nonidentical unrelated canine model.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1198-200.
2006: Baron Frédéric; Storer Barry; Maris Michael B; Storek Jan; Piette Fanny; Metcalf Monja; White Kristen; Sandmaier Brenda M; Maloney David G; Storb Rainer; Boeckh Michael
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1176-87.
2006: Yunusov Murad Y; Kuhr Christian S; Georges George E; Hogan William J; Taranova Anna G; Lesnikova Marina; Kim Yang-Soo; Abrams Kraig; Hwang Billanna; Sale George E; Storer Barry; Storb Rainer; Nash Richard A
Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft.
Transplantation 2006;82(5):629-37.
2006: Robien Kim; Bigler Jeannette; Yasui Yutaka; Potter John D; Martin Paul; Storb Rainer; Ulrich Cornelia M
Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(9):973-80.
2006: Mielcarek Marco; Georges George E; Storb Rainer
Denileukin diftitox as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(9):899-904.
2006: Baron Frédéric; Storb Rainer; Storer Barry E; Maris Michael B; Niederwieser Dietger; Shizuru Judith A; Chauncey Thomas R; Bruno Benedetto; Forman Stephen J; McSweeney Peter A; Maziarz Richard T; Pulsipher Michael A; Agura Edward D; Wade James; Sorror Mohamed; Maloney David G; Sandmaier Brenda M
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
2006: Fukuda Takahiro; Kerbauy Fabio R; Gooley Theodore; Santos Erlinda B; Storb Rainer; Sandmaier Brenda M
Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
Transplantation 2006;82(3):332-9.
2006: Jochum Christoph; Beste Mechthild; Zellmer Eustacia; Graves Scott S; Storb Rainer; Storb Rainer
Donor-specific mononuclear cell transfusion and methotrexate as pretransplant treatment in dogs given DLA-identical marrow grafts after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):885-6.
2006: Jochum Christoph; Beste Mechthild; Zellmer Eustacia; Graves Scott S; Storb Rainer; Storb Rainer
Donor-specific mononuclear cell transfusion and methotrexate as pretransplant treatment in dogs given DLA-identical marrow grafts after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):885-6.
2006: Baron Frédéric; Sandmaier Brenda M; Zellmer Eustacia; Sorror Mohamed; Storer Barry; Storb Rainer
Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):813-7.
2006: Gopal Ajay K; Pagel John M; Rajendran Joseph G; Maloney David G; Appelbaum Frederick R; Sorror Mohamed L; Sandmaier Brenda M; Storb Rainer; Press Oliver W
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):697-702.
2006: Nash Richard A; McSweeney Peter A; Nelson J Lee; Wener Mark; Georges George E; Langston Amelia A; Shulman Howard; Sullivan Keith M; Lee Julie; Henstorf Gretchen; Storb Rainer; Furst Daniel E
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
Arthritis and rheumatism 2006;54(6):1982-6.
2006: Kuhr Christian S; Lupu Marilena; Little Marie-Térèse; Zellmer Eustacia; Sale George E; Storb Rainer
RDP58 does not prevent graft-versus-host disease after dog leukocyte antigen-nonidentical canine hematopoietic cell transplantation.
Transplantation 2006;81(10):1460-2.
2006: Storb Rainer
In response to transplantation 2006; 80: 1145-1152.
Transplantation 2006;81(9):1357; author reply 1357-8.
2006: Deeg H Joachim; Storer Barry E; Boeckh Michael; Martin Paul J; McCune Jeannine S; Myerson David; Heimfeld Shelly; Flowers Mary E; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Nash Richard A; O'Donnell Paul V; Radich Jerald P; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed L; Warren E Houston; Witherspoon Robert P; Woolfrey Ann; Appelbaum Frederick R; Storb Rainer
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
2006: Maris Michael B; Sandmaier Brenda M; Storer Barry E; Maloney David G; Shizuru Judith A; Agura Edward; Kliem Constanze; Pulsipher Michael; Maziarz Richard T; McSweeney Peter A; Wade James; Langston Amelia A; Chauncey Thomas R; Bruno Benedetto; Blume Karl G; Storb Rainer
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):454-65.
2006: Robien K; Schubert M M; Yasui Y; Martin P; Storb R; Potter J D; Ulrich C M
Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation.
Bone marrow transplantation 2006;37(7):687-92.
2006: Robien K; Schubert M M; Chay T; Bigler J; Storb R; Yasui Y; Potter J D; Ulrich C M
Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation.
Bone marrow transplantation 2006;37(8):799-800.
2006: Burroughs Lauri; Mielcarek Marco; Leisenring Wendy; Sandmaier Brenda M; Maloney David G; Baron Frédéric; Martin Paul J; Flowers Mary E D; Forman Stephen J; Chauncey Thomas R; Bruno Benedetto; Storb Rainer
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 2006;81(6):818-25.
2006: Lupu Marilena; Sullivan Edmund W; Westfall Theresa E; Little Marie-Térèse; Weigler Benjamin J; Moore Peter F; Stroup Patrice A; Zellmer Eustacia; Kuhr Christian; Storb Rainer
Use of multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma.
Journal of the American Veterinary Medical Association 2006;228(5):728-32.
2006: Mielcarek Marco; Bryant Eileen; Loken Michael; Zaucha Jan Maciej; Torok-Storb Beverly; Storb Rainer
Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation.
Blood 2006;107(4):1732-3.
2006: Hegenbart Ute; Niederwieser Dietger; Sandmaier Brenda M; Maris Michael B; Shizuru Judith A; Greinix Hildegard; Cordonnier Catherine; Rio Bernard; Gratwohl Alois; Lange Thoralf; Al-Ali Haifa; Storer Barry; Maloney David; McSweeney Peter; Chauncey Thomas; Agura Ed; Bruno Benedetto; Maziarz Richard T; Petersen Finn; Storb Rainer
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):444-53.
2006: Baron Frédéric; Storb Rainer
Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;13(1):26-41.
2006: Scott B L; Sandmaier B M; Storer B; Maris M B; Sorror M L; Maloney D G; Chauncey T R; Storb R; Deeg H J
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):128-35.
2006: Baron Frédéric; Storb Rainer
The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspective.
Best practice & research. Clinical haematology 2006;19(4):637-53.
2005: Burroughs Lauri; Mielcarek Marco; Little Marie-Térèse; Bridger Gary; Macfarland Ron; Fricker Simon; Labrecque Jean; Sandmaier Brenda M; Storb Rainer
Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.
Blood 2005;106(12):4002-8.
2005: Panse Jens P; Storb Rainer; Storer Barry; Santos Erlinda B; Wentzel Collette; Sandmaier Brenda M
Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation.
Transplantation 2005;80(10):1518-21.
2005: Baron Frédéric; Storb Rainer
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.
Clinical advances in hematology & oncology : H&O 2005;3(10):799-819.
2005: Sorror Mohamed L; Leisenring Wendy; Deeg H Joachim; Martin Paul J; Storb Rainer
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(10):814-5.
2005: Sorror Mohamed L; Maris Michael B; Storb Rainer; Baron Frederic; Sandmaier Brenda M; Maloney David G; Storer Barry
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Blood 2005;106(8):2912-9.
2005: Kerbauy Daniella M B; Chyou Faith; Gooley Ted; Sorror Mohamed L; Scott Bart; Pagel John M; Myerson David; Appelbaum Frederick R; Storb Rainer; Deeg H Joachim
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):713-20.
2005: Kahl Christoph; Leisenring Wendy; Deeg H Joachim; Chauncey Thomas R; Flowers Mary E D; Martin Paul J; Sanders Jean E; Storb Rainer
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
British journal of haematology 2005;130(5):747-51.
2005: Mielcarek Marco; Storb Rainer
Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation.
Leukemia & lymphoma 2005;46(9):1251-60.
2005: Giaccone L; Martin P; Carpenter P; Moravec C; Hooper H; Funke V A M; Storb R; Flowers M E D
Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease.
Bone marrow transplantation 2005;36(4):337-41.
2005: Sorror Mohamed L; Leisenring Wendy; Deeg H Joachim; Martin Paul J; Storb Rainer
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):567-8.
2005: Nash Richard A; Johnston Laura; Parker Pablo; McCune Jeannine S; Storer Barry; Slattery John T; Furlong Terry; Anasetti Claudio; Appelbaum Frederick R; Lloid Michele E; Deeg H Joachim; Kiem Hans-Peter; Martin Paul J; Schubert Mark M; Witherspoon Robert P; Forman Stephen J; Blume Karl G; Storb Rainer
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):495-505.
2005: Zanis-Neto J; Flowers M E D; Medeiros C R; Bitencourt M A; Bonfim C M; Setúbal D C; Funke V; Sanders J; Deeg H J; Kiem H P; Martin P; Leisenring W; Storb R; Pasquini R
Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia.
British journal of haematology 2005;130(1):99-106.
2005: Sorror Mohamed L; Maris Michael B; Sandmaier Brenda M; Storer Barry E; Stuart Monic J; Hegenbart Ute; Agura Edward; Chauncey Thomas R; Leis Jose; Pulsipher Michael; McSweeney Peter; Radich Jerald P; Bredeson Christopher; Bruno Benedetto; Langston Amelia; Loken Michael R; Al-Ali Haifa; Blume Karl G; Storb Rainer; Maloney David G
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3819-29.
2005: Kerbauy F R; Storb R; Hegenbart U; Gooley T; Shizuru J; Al-Ali H K; Radich J P; Maloney D G; Agura E; Bruno B; Epner E M; Chauncey T R; Blume K G; Niederwieser D; Sandmaier B M
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):990-7.
2005: Diaconescu Razvan; Little Marie-Térèse; Leisenring Wendy; Yunusov Murad; Hogan William J; Sorror Mohamed L; Baron Frédéric; Storb Rainer
What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):335-44.
2005: Mielcarek Marco; Burroughs Lauri; Leisenring Wendy; Diaconescu Razvan; Martin Paul J; Sandmaier Brenda M; Maloney David G; Maris Michael B; Chauncey Thomas R; Shizuru Judith A; Blume Karl G; Hegenbart Ute; Niederwieser Dietger; Forman Stephen; Bruno Benedetto; Woolfrey Ann; Storb Rainer
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 2005;129(3):381-91.
2005: Wallen Herschel; Gooley Theodore A; Deeg H Joachim; Pagel John M; Press Oliver W; Appelbaum Frederick R; Storb Rainer; Gopal Ajay K
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3439-46.
2005: Baron F; Maris M B; Storer B E; Sandmaier B M; Panse J P; Chauncey T R; Sorror M; Little M-T; Maloney D G; Storb R; Heimfeld S
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):822-8.
2005: Baron Frédéric; Little Marie-Térèse; Storb Rainer
Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning.
Blood reviews 2005;19(3):153-64.
2005: Baron Frédéric; Maris Michael B; Storer Barry E; Sandmaier Brenda M; Stuart Monic J; McSweeney Peter A; Radich Jerald P; Pulsipher Michael A; Agura Edward D; Chauncey Thomas R; Maloney David G; Shizuru Judith A; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):272-9.
2005: Baron Frédéric; Maris Michael B; Sandmaier Brenda M; Storer Barry E; Sorror Mohamed; Diaconescu Razvan; Woolfrey Ann E; Chauncey Thomas R; Flowers Mary E D; Mielcarek Marco; Maloney David G; Storb Rainer
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1993-2003.
2005: Parikh Chirag R; Schrier Robert W; Storer Barry; Diaconescu Razvan; Sorror Mohamed L; Maris Michael B; Maloney David G; McSweeney Peter; Storb Rainer; Sandmaier Brenda M
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(3):502-9.
2005: Sorror Mohamed; Maris Michael; Diaconescu Razvan; Storb Rainer
Lessened severe graft-versus-host after "minitransplantations".
Blood 2005;105(6):2614.
2005: Mielcarek Marco; Gooley Theodore; Martin Paul J; Chauncey Thomas R; Young Bessie A; Storb Rainer; Torok-Storb Beverly
Effects of race on survival after stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):231-9.
2005: Panse J P; Heimfeld S; Guthrie K A; Maris M B; Maloney D G; Baril B B; Little M-T; Chauncey T R; Storer B E; Storb R; Sandmaier B M
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
British journal of haematology 2005;128(5):659-67.
2005: Flowers M E D; Traina F; Storer B; Maris M; Bethge W A; Carpenter P; Appelbaum F; Storb R; Sandmaier B M; Martin P J
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning.
Bone marrow transplantation 2005;35(3):277-82.
2005: Scott Bart L; Storer Barry; Loken Michael R; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):65-73.
2005: Burroughs Lauri; Storb Rainer
Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease.
Current opinion in hematology 2005;12(1):45-54.
2005: Diaconescu Razvan; Storb Rainer
Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care.
Journal of cancer research and clinical oncology 2005;131(1):1-13.
2005: Maris Michael B; Storb Rainer
Allogeneic hematopoietic cell transplantation as consolidation immunotherapy of cancer after autologous transplantation.
Acta haematologica 2005;114(4):221-9.
2004: Tykodi Scott S; Warren Edus H; Thompson John A; Riddell Stanley R; Childs Richard W; Otterud Brith E; Leppert Mark F; Storb Rainer; Sandmaier Brenda M
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7799-811.
2004: Storek Jan; Zhao Zhao; Lin Eugene; Berger Thomas; McSweeney Peter A; Nash Richard A; Akatsuka Yoshiki; Metcalf Monja D; Lu Hailing; Kalina Tomas; Reindl Markus; Storb Rainer; Hansen John A; Sullivan Keith M; Kraft George H; Furst Daniel E; Maloney David G
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).
Clinical immunology (Orlando, Fla.) 2004;113(3):285-98.
2004: Dell'Agnola Chiara; Wang Zejing; Storb Rainer; Tapscott Stephen J; Kuhr Christian S; Hauschka Stephen D; Lee Richard S; Sale George E; Zellmer Eustacia; Gisburne Serina; Bogan Janet; Kornegay Joe N; Cooper Barry J; Gooley Theodore A; Little Marie-Térèse
Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.
Blood 2004;104(13):4311-8.
2004: Maris Michael B; Sandmaier Brenda M; Storer Barry E; Chauncey Thomas; Stuart Monic Jain; Maziarz Richard T; Agura Edward; Langston Amelia A; Pulsipher Michael; Storb Rainer; Maloney David G
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood 2004;104(12):3535-42.
2004: Stewart Betty L; Storer Barry; Storek Jan; Deeg H Joachim; Storb Rainer; Hansen John A; Appelbaum Frederick R; Carpenter Paul A; Sanders Jean E; Kiem Hans-Peter; Nash Richard A; Petersdorf Effie W; Moravec Carina; Morton A James; Anasetti Claudio; Flowers Mary E D; Martin Paul J
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Blood 2004;104(12):3501-6.
2004: Baron Frédéric; Storb Rainer
Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review.
Springer seminars in immunopathology 2004;26(1-2):71-94.
2004: Lee Je-Hwan; Joo Young-Don; Yim Daesong; Lee Richard; Ostrander Elaine A; Loretz Carol; Little Marie-Térèse; Storb Rainer; Kuhr Christian S
Molecular cloning and characterization of canine ICOS.
Genomics 2004;84(4):730-6.
2004: Baron Frédéric; Baker Jennifer E; Storb Rainer; Gooley Theodore A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Heimfeld Shelly; Oparin Dmitrij; Zellmer Eustacia; Radich Jerald P; Grumet F Carl; Blume Karl G; Chauncey Thomas R; Little Marie-Térèse
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2004;104(8):2254-62.
2004: Lange T; Deininger M; Brand R; Hegenbart U; Al-Ali H; Krahl R; Poenisch W; Uharek L; Leiblein S; Gentilini C; Petersdorf E; Storb R F; Niederwieser D
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(9):1468-75.
2004: Diaconescu Razvan; Flowers Christopher R; Storer Barry; Sorror Mohamed L; Maris Michael B; Maloney David G; Sandmaier Brenda M; Storb Rainer
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Blood 2004;104(5):1550-8.
2004: Bethge Wolfgang A; Wilbur D Scott; Storb Rainer; Hamlin Donald K; Santos Erlinda B; Brechbiel Martin W; Sandmaier Brenda M
Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study.
Transplantation 2004;78(3):352-9.
2004: Martin Paul J; Pei Ji; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Deeg Joachim; Hansen John A; Nash Richard A; Petersdorf Effie W; Storb Rainer; Ghetie Victor; Schindler John; Vitetta Ellen S
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(8):552-60.
2004: Sorror Mohamed L; Maris Michael B; Storer Barry; Sandmaier Brenda M; Diaconescu Razvan; Flowers Christopher; Maloney David G; Storb Rainer
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Blood 2004;104(4):961-8.
2004: Storb Rainer
Non-myeloablative allogeneic transplantation -- state-of-the-art.
Pediatric transplantation 2004;8 Suppl 5():12-8.
2004: Storb Rainer
History of pediatric stem cell transplantation.
Pediatric transplantation 2004;8 Suppl 5():5-11.
2004: Martin Paul J; McDonald George B; Sanders Jean E; Anasetti Claudio; Appelbaum Frederick R; Deeg H Joachim; Nash Richard A; Petersdorf Effie W; Hansen John A; Storb Rainer
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):320-7.
2004: Yusuf U; Frangoul H A; Gooley T A; Woolfrey A E; Carpenter P A; Andrews R G; Deeg H J; Appelbaum F R; Anasetti C; Storb R; Sanders J E
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.
Bone marrow transplantation 2004;33(8):805-14.
2004: Bethge Wolfgang A; Hegenbart Ute; Stuart Monic J; Storer Barry E; Maris Michael B; Flowers Mary E D; Maloney David G; Chauncey Thomas; Bruno Benedetto; Agura Ed; Forman Stephen J; Blume Karl G; Niederwieser Dietger; Storb Rainer; Sandmaier Brenda M
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Blood 2004;103(3):790-5.
2004: Mielcarek Marco; Martin Paul J; Heimfeld Shelly; Storb Rainer; Torok-Storb Beverly
CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
Leukemia & lymphoma 2004;45(1):27-34.
2004: Hogan William J; Maris Michael; Storer Barry; Sandmaier Brenda M; Maloney David G; Schoch H Gary; Woolfrey Ann E; Shulman Howard M; Storb Rainer; McDonald George B
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.
Blood 2004;103(1):78-84.
2004: Bensinger William I; Buckner C Dean; Lilleby Kathy; Holmberg Leona; Storb Rainer; Slattery John T
Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants.
Oncology 2004;67(5-6):368-75.
2003: Deeg H Joachim; Gooley Theodore A; Flowers Mary E D; Sale George E; Slattery John T; Anasetti Claudio; Chauncey Thomas R; Doney Kristine; Georges George E; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie W; Radich Jerald; Sanders Jean E; Sandmaier Brenda M; Warren E Houston; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
2003: Baron Frédéric; Storb Rainer; Little Marie-Térèse
Hematopoietic cell transplantation: five decades of progress.
Archives of medical research 2003;34(6):528-44.
2003: Hegenbart U; Niederwieser D; Forman S; Holler E; Leiblein S; Johnston L; Pönisch W; Epner E; Witherspoon R; Blume K; Storb R
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(11):689-97.
2003: Takatu Alessandra; Nash Richard A; Zaucha Jan M; Little Marie-Terese; Georges George E; Sale George E; Zellmer Eustacia; Kuhr Christian S; Lothrop Clinton D; Storb Rainer
Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(11):674-82.
2003: Junghanss Christian; Storb Rainer; Maris Michael B; Carter Rachel A; Sandmaier Brenda M; Maloney David G; McSweeney Peter A; Corey Lawrence; Boeckh Michael
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 2003;123(4):662-70.
2003: Maloney David G; Molina Arthur J; Sahebi Firoozeh; Stockerl-Goldstein Keith E; Sandmaier Brenda M; Bensinger William; Storer Barry; Hegenbart Ute; Somlo George; Chauncey Thomas; Bruno Benedetto; Appelbaum Frederick R; Blume Karl G; Forman Stephen J; McSweeney Peter; Storb Rainer
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
2003: Lee Richard S; Kuhr Christian S; Sale George E; Zellmer Eustacia; Hogan William J; Storb Rainer; Little Marie-Térèse
FTY720 does not abrogate acute graft-versus-host disease in the dog leukocyte antigen-nonidentical unrelated canine model.
Transplantation 2003;76(8):1155-8.
2003: Bethge Wolfgang A; Storer Barry E; Maris Michael B; Flowers Mary E D; Maloney David G; Chauncey Thomas R; Woolfrey Ann E; Storb Rainer; Sandmaier Brenda M
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.
Experimental hematology 2003;31(10):974-80.
2003: Maris Michael; Boeckh Michael; Storer Barry; Dawson Monja; White Kristen; Keng Michael; Sandmaier Brenda; Maloney David; Storb Rainer; Storek Jan
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning.
Experimental hematology 2003;31(10):941-52.
2003: Nash Richard A; Bowen James D; McSweeney Peter A; Pavletic Steven Z; Maravilla Kenneth R; Park Man-soo; Storek Jan; Sullivan Keith M; Al-Omaishi Jinan; Corboy John R; DiPersio John; Georges George E; Gooley Theodore A; Holmberg Leona A; LeMaistre C Fred; Ryan Kate; Openshaw Harry; Sunderhaus Julie; Storb Rainer; Zunt Joseph; Kraft George H
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
Blood 2003;102(7):2364-72.
2003: Chen Chien-Shing; Boeckh M; Seidel K; Clark J G; Kansu E; Madtes D K; Wagner J L; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W I; Deeg H J; Martin P J; Sanders J E; Storb R; Storek J; Wade J; Siadak M; Flowers M E D; Sullivan K M
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;32(5):515-22.
2003: Guardiola Philippe; Kurre Peter; Vlad Amalia; Cayuela Jean-Michel; Espérou Hélène; Devergie Agnès; Ribaud Patricia; Socié Gérard; Richard Patrice; Traineau Richard; Storb Rainer; Gluckman Eliane
Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia.
British journal of haematology 2003;122(5):806-9.
2003: Maris Michael B; Niederwieser Dietger; Sandmaier Brenda M; Storer Barry; Stuart Monic; Maloney David; Petersdorf Effie; McSweeney Peter; Pulsipher Michael; Woolfrey Ann; Chauncey Thomas; Agura Ed; Heimfeld Shelly; Slattery John; Hegenbart Ute; Anasetti Claudio; Blume Karl; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
Blood 2003;102(6):2021-30.
2003: Storb Rainer
What role for mycophenolate mofetil in allogeneic hematopoietic cell transplantation?
Transplantation 2003;76(4):747.
2003: Hogan William J; Little Marie-Térèse; Zellmer Eustacia; Friedetzky Anke; Diaconescu Razvan; Gisburne Serina; Lee Richard; Kuhr Christian; Storb Rainer
Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(8):489-95.
2003: Mielcarek Marco; Storb Rainer
Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies.
Cancer treatment reviews 2003;29(4):283-90.
2003: Panse Jens P; Bastianelli Carla; Santos Erlinda B; Schwarzinger Ilse; Raff Robert F; Storb Rainer; Sandmaier Brenda M
Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cells.
Transplantation 2003;76(3):474-80.
2003: Doney Kristine; Hägglund Hans; Leisenring Wendy; Chauncey Thomas; Appelbaum Frederick R; Storb Rainer
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):472-81.
2003: Mielcarek Marco; Martin Paul J; Leisenring Wendy; Flowers Mary E D; Maloney David G; Sandmaier Brenda M; Maris Michael B; Storb Rainer
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Blood 2003;102(2):756-62.
2003: Georges G E; Storb R; Maciej Zaucha J; Taranova A G; Gooley T; Nash R A
IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs.
Bone marrow transplantation 2003;31(11):1027-31.
2003: Bethge Wolfgang A; Wilbur D Scott; Storb Rainer; Hamlin Donald K; Santos Erlinda B; Brechbiel Martin W; Fisher Darrell R; Sandmaier Brenda M
Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.
Blood 2003;101(12):5068-75.
2003: Abrams Kraig; Yunusov Murad Y; Slichter Sherrill; Moore Peter; Nelp Wil B; Burstein Samuel A; McDonough Sean; Durack Lawrence; Storer Barry; Storb Rainer; Gass M John; Georges George; Nash Richard A
Recombinant human macrophage colony-stimulating factor-induced thrombocytopenia in dogs.
British journal of haematology 2003;121(4):614-22.
2003: Georges George E; Lesnikova Marina; Storb Rainer; Yunusov Murad; Little Marie-Térèse; Nash Richard A
Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(4):234-42.
2003: Yunusov Murad Y; Georges George E; Storb Rainer; Moore Peter; Hagglund Hans; Affolter Verena; Lesnikova Marina; Gass M John; Little Marie-Térèse; Loken Michael; McKenna Hilary; Storer Barry; Nash Richard A
FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease.
Transplantation 2003;75(7):933-40.
2003: Sandmaier Brenda M; Fukuda Takahiro; Gooley Theodore; Yu Cong; Santos Erlinda B; Storb Rainer
Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.
Experimental hematology 2003;31(2):168-75.
2003: Junghanss Christian; Takatu Alessandra; Little Marie-Terese; Maciej Zaucha J; Zellmer Eustacia; Yunusov Murad; Sale George; Georges George E; Storb Rainer
Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
Transplantation 2003;75(3):268-74.
2003: Mielcarek Marco; Torok-Storb Beverly; Storb Rainer
Is alloantigen expression by host epithelium required for acute graft-versus-host disease?
Nature medicine 2003;9(2):150-1; author reply 151.
2003: Georges George E; Storb Rainer
Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.
International journal of hematology 2003;77(1):3-14.
2003: Storb Rainer
Allogeneic hematopoietic stem cell transplantation--yesterday, today, and tomorrow.
Experimental hematology 2003;31(1):1-10.
2003: Maris Michael; Storb Rainer
The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases.
Immunologic research 2003;28(1):13-24.
2003: Hogan William J; Storb Rainer
Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease.
Immunologic research 2003;28(1):1-11.
2002: Yunusov M Y; Kuhr C; Georges G E; Sale G E; Spector M; Lesnikova M; Lee R; Little M-T; Gass M J; Weber K; Joslyn A; Storb R; Nash R A
Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results.
Transplantation proceedings 2002;34(8):3366-7.
2002: Maciej Zaucha J; Mielcarek Marco; Takatu Alessandra; Little Marie-Terese; Gooley Theodore; Baker Jennifer; Maloney David G; Sandmaier Brenda M; Maris Michael; Chauncey Thomas; Storb Rainer; Torok-Storb Beverly
Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):740-50.
2002: Lee Richard; Storb Rainer; Little Marie-Térèse; Joslyn Alix; Spector Michele; Kuhr Christian S
Percutaneous central dual-lumen catheter for apheresis in the canine.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 2002;15(6):337-41.
2002: Kobbe Guido; Germing Ulrich; Aivado Manuel; Zohren Fabian; Schubert Dominik; Strupp Corinna; Pape Hildegard; Tenderich Gero; Körfer Reiner; Storb Rainer; Haas Rainer; Schneider Peter
Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation.
Transplantation 2002;74(8):1198-200.
2002: Hogan William J; Storb Rainer
Clinical developments in reduced intensity haematopoietic stem cell transplantation.
Expert opinion on biological therapy 2002;2(7):703-14.
2002: McSweeney Peter A; Nash Richard A; Sullivan Keith M; Storek Jan; Crofford Leslie J; Dansey Roger; Mayes Maureen D; McDonagh Kevin T; Nelson J Lee; Gooley Theodore A; Holmberg Leona A; Chen C S; Wener Mark H; Ryan Katherine; Sunderhaus Julie; Russell Ken; Rambharose John; Storb Rainer; Furst Daniel E
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
Blood 2002;100(5):1602-10.
2002: Woolfrey Ann E; Pulsipher Michael A; Storb Rainer
Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children.
International journal of hematology 2002;76 Suppl 2():271-7.
2002: Georges George E; Maris Michael; Sandmaier Brenda M; Malone David G; Feinstein Lyle; Niederweiser Dietger; Shizuru Judith A; McSweeney Peter A; Chauncey Thomas R; Agura Edward; Little Marie-Trse; Sahebi Firoozeh; Hegenbart Ute; Pulsipher Michael A; Bruno Benedetto; Forman Stephen; Woolfrey Ann E; Radich Jerald P; Blume Karl G; Storb Rainer
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
International journal of hematology 2002;76 Suppl 1():184-9.
2002: Deeg H Joachim; Storer Barry; Slattery John T; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie; Radich Jerald P; Sanders Jean E; Shulman Howard M; Warren Edus H; Witherspoon Robert P; Bryant Eileen M; Chauncey Thomas R; Getzendaner Lisa; Storb Rainer; Appelbaum Frederick R
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: Platzbecker Uwe; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Clurman Bruce; Doney Kris; Chauncey Thomas; Flowers Mary E D; Myerson David; Radich Jerald P; Storb Rainer; Witherspoon Robert P; Deeg H Joachim
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
Leukemia & lymphoma 2002;43(7):1409-14.
2002: Flowers Mary E D; Parker Pablo M; Johnston Laura J; Matos Alice V B; Storer Barry; Bensinger William I; Storb Rainer; Appelbaum Frederick R; Forman Stephen J; Blume Karl G; Martin Paul J
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Blood 2002;100(2):415-9.
2002: Sandmaier Brenda M; Bethge Wolfgang A; Wilbur D Scott; Hamlin Donald K; Santos Erlinda B; Brechbiel Martin W; Fisher Darrell R; Storb Rainer
Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
Blood 2002;100(1):318-26.
2002: Koc Sibel; Leisenring Wendy; Flowers Mary E D; Anasetti Claudio; Deeg H Joachim; Nash Richard A; Sanders Jean E; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Blood 2002;100(1):48-51.
2002: Kuhr Christian S; Allen Margaret D; Junghanss Christian; Zaucha Jan M; Marsh Christopher L; Yunusov Murad; Zellme Eustacia; Little Marie-Térèse; Torok-Storb Beverly; Storb Rainer
Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras.
Transplantation 2002;73(9):1487-92.
2002: Storb R
Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(4):753-4.
2002: Carpenter Paul A; Appelbaum Frederick R; Corey Lawrence; Deeg H Joachim; Doney Kris; Gooley Theodore; Krueger James; Martin Paul; Pavlovic Sandra; Sanders Jean; Slattery John; Levitt Daniel; Storb Rainer; Woolfrey Ann; Anasetti Claudio
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.
Blood 2002;99(8):2712-9.
2002: Wagner J L; Sarmiento U M; Storb R
Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine Major Histocompatibility Complex.
Tissue antigens 2002;59(3):205-10.
2002: Mielcarek Marco; Sandmaier Brenda M; Maloney David G; Maris Michael; McSweeney Peter A; Woolfrey Ann; Chauncey Thomas; Feinstein Lyle; Niederwieser Dietger; Blume Karl G; Forman Stephen; Torok-Storb Beverly; Storb Rainer
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.
Journal of clinical immunology 2002;22(2):70-4.
2002: Little Marie-Térèse; Storb Rainer
History of haematopoietic stem-cell transplantation.
Nature reviews. Cancer 2002;2(3):231-8.
2002: Junghanss Christian; Boeckh Michael; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Chauncey Thomas; McSweeney Peter A; Little Marie-Térèse; Corey Lawrence; Storb Rainer
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.
Blood 2002;99(6):1978-85.
2002: Georges George E; Storb Rainer
Stem cell transplantation for aplastic anemia.
International journal of hematology 2002;75(2):141-6.
2002: Mielcarek Marco; Zaucha J Maciej; Sandmaier Brenda; Maloney David; Butrynski James; Maris Michael; Feinstein Lyle; Torok-Storb Beverly; Storb Rainer
Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility.
British journal of haematology 2002;116(2):500-1.
2002: Xun Chang-Qing; Little Marie-Térèse; Zellmer Eustacia; Yu Cong; Zaucha Jan M; Sale George E; Storer Barry; Storb Rainer
What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?
Transplantation 2002;73(2):310-3.
2002: Warren E H; Tykodi S S; Murata M; Sandmaier B M; Storb R; Jaffee E; Childs R; Thompson J A; Greenberg P D; Riddell S R
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma.
Cytotherapy 2002;4(5):441.
2002: Junghanss Christian; Marr Kieren A; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Chauncey Thomas; McSweeney Peter A; Storb Rainer
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):512-20.
2002: Storb R
Perspective: haematopoietic stem cell rescue enabling high-dose chemotherapy, tool for immunotherapy.
Developments in biologicals 2002;108():123-6.
2002: Nash Richard A; Takatu Alessandra; Feng Ziding; Slichter Sherrill; Abrams Kraig; Espino German; Gass M John; Georges George E; McSweeney Peter A; Shulman Howard M; Storb Rainer
Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):360-7.
2002: Furlong Terry; Leisenring Wendy; Storb Rainer; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Kiem Hans-Peter; Nash Richard A; Sanders Jean E; Witherspoon Robert; Thompson Dianne; Martin Paul J
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):206-12.
2002: Jurado Manuel; Deeg H Joachim; Storer Barry; Anasetti Claudio; Anderson Jeanne E; Bryant Eileen; Chauncey Thomas; Doney Kris; Flowers Mary E D; Hansen John; Martin Paul J; Nash Richard A; Petersdorf Effie; Radich Jerry; Sale George; Sandmaier Brenda M; Storb Rainer; Wade James; Witherspoon Robert; Appelhaum Frederick R
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):161-9.
2002: Maris Michael; Storb Rainer
Outpatient allografting in hematologic malignancies and nonmalignant disorders--applying lessons learned in the canine model to humans.
Cancer treatment and research 2002;110():149-75.
2002: Goerner Martin; Gooley Theodore; Flowers Mary E D; Sullivan Keith M; Kiem Hans-Peter; Sanders Jean E; Martin Paul J; Storb Rainer
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(1):47-56.
2001: Benito A I; Furlong T; Martin P J; Anasetti C; Appelbaum F R; Doney K; Nash R A; Papayannopoulou T; Storb R; Sullivan K M; Witherspoon R; Deeg H J
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Transplantation 2001;72(12):1924-9.
2001: Woolfrey A; Pulsipher M A; Storb R
Nonmyeloablative hematopoietic cell transplant for treatment of immune deficiency.
Current opinion in pediatrics 2001;13(6):539-45.
2001: Kansu E; Gooley T; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Blood 2001;98(13):3868-70.
2001: Weissinger F; Sandmaier B M; Maloney D G; Bensinger W I; Gooley T; Storb R
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Blood 2001;98(13):3584-8.
2001: Storek J; Joseph A; Espino G; Dawson M A; Douek D C; Sullivan K M; Flowers M E; Martin P; Mathioudakis G; Nash R A; Storb R; Appelbaum F R; Maloney D G
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
Blood 2001;98(13):3505-12.
2001: Georges G E; Storb R; Bruno B; Brodie S J; Thompson J D; Taranova A G; Zaucha J M; Little M T; Zellmer E; Moore P F; Gooley T; Sale G; Kiem H P; Sandmaier B M; Lyons R M; Nash R A
Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes.
Blood 2001;98(12):3447-55.
2001: Zaucha J M; Gooley T; Bensinger W I; Heimfeld S; Chauncey T R; Zaucha R; Martin P J; Flowers M E; Storek J; Georges G; Storb R; Torok-Storb B
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation.
Blood 2001;98(12):3221-7.
2001: Feinstein L; Storb R
Reducing transplant toxicity.
Current opinion in hematology 2001;8(6):342-8.
2001: Goerner M; Horn P A; Peterson L; Kurre P; Storb R; Rasko J E; Kiem H P
Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors.
Blood 2001;98(7):2065-70.
2001: Maris M; Woolfrey A; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D; Storb R
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century.
Frontiers in bioscience : a journal and virtual library 2001;6():G13-6.
2001: Bensinger W I; Maloney D; Storb R
Allogeneic hematopoietic cell transplantation for multiple myeloma.
Seminars in hematology 2001;38(3):243-9.
2001: Zaucha J M; Yu C; Mathioudakis G; Seidel K; Georges G; Sale G; Little M T; Torok-Storb B; Storb R
Hematopoietic responses to stress conditions in young dogs compared with elderly dogs.
Blood 2001;98(2):322-7.
2001: Ulrich C M; Yasui Y; Storb R; Schubert M M; Wagner J L; Bigler J; Ariail K S; Keener C L; Li S; Liu H; Farin F M; Potter J D
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism.
Blood 2001;98(1):231-4.
2001: Maris M; Sandmaier B M; Maloney D G; McSweeney P A; Woolfrey A; Chauncey T; Shizuru J; Niederwieser D; Blume K G; Forman S; Storb R
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):231-4.
2001: Bensinger W I; Storb R
Allogeneic peripheral blood stem cell transplantation.
Reviews in clinical and experimental hematology 2001;5(2):67-86.
2001: Feinstein L; Sandmaier B; Maloney D; McSweeney P A; Maris M; Flowers C; Radich J; Little M T; Nash R A; Chauncey T; Woolfrey A; Georges G; Kiem H P; Zaucha J M; Blume K G; Shizuru J; Niederwieser D; Storb R
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Annals of the New York Academy of Sciences 2001;938():328-37; discussion 337-9.
2001: McSweeney P A; Niederwieser D; Shizuru J A; Sandmaier B M; Molina A J; Maloney D G; Chauncey T R; Gooley T A; Hegenbart U; Nash R A; Radich J; Wagner J L; Minor S; Appelbaum F R; Bensinger W I; Bryant E; Flowers M E; Georges G E; Grumet F C; Kiem H P; Torok-Storb B; Yu C; Blume K G; Storb R F
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
2001: Storek J; Dawson M A; Storer B; Stevens-Ayers T; Maloney D G; Marr K A; Witherspoon R P; Bensinger W; Flowers M E; Martin P; Storb R; Appelbaum F R; Boeckh M
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Blood 2001;97(11):3380-9.
2001: Al-Ghamdi H; Leisenring W; Bensinger W I; Nash R A; Storb R; Appelbaum F R; Martin P J
A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest.
British journal of haematology 2001;113(2):461-9.
2001: Storb R
Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(4):662-3.
2001: Buckner C D; Epstein R B; Rudolph R H; Clift R A; Storb R; Thomas E D
Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. 1970.
Journal of hematotherapy & stem cell research 2001;10(2):201-8.
2001: Witherspoon R P; Deeg H J; Storer B; Anasetti C; Storb R; Appelbaum F R
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2134-41.
2001: Feinstein L; Storb R
Nonmyeloablative hematopoietic cell transplantation.
Current opinion in oncology 2001;13(2):95-100.
2001: Jurado M; Deeg H; Gooley T; Anasetti C; Chauncey T; Flowers M; Myerson D; Storb R; Appelbaum F
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia.
British journal of haematology 2001;112(2):392-6.
2001: Bensinger W I; Martin P J; Storer B; Clift R; Forman S J; Negrin R; Kashyap A; Flowers M E; Lilleby K; Chauncey T R; Storb R; Appelbaum F R
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
The New England journal of medicine 2001;344(3):175-81.
2001: Zaucha J M; Zellmer E; Georges G; Little M T; Storb R; Storer B; Torok-Storb B
G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(11):613-9.
2001: Bruno B; Goerner M A; Nash R A; Storb R; Kiem H P; McSweeney P A
Purified canine CD34+Lin- marrow cells transduced with retroviral vectors give rise to long-term multi-lineage hematopoiesis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):543-51.
2001: Zaucha J M; Yu C; Zellmer E; Takatu A; Junghanss C; Little M T; Storb R
Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(9):513-6.
2001: Wagner J L; Flowers M E; Longton G; Storb R; Martin P
Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):239-40.
2001: Anderson J E; Appelbaum F R; Schoch G; Barnett T; Chauncey T R; Flowers M E; Storb R
Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(3):163-70.
2001: Bruno B; Gooley T; Sullivan K M; Davis C; Bensinger W I; Storb R; Nash R A
Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(3):154-62.
2001: Storb R; Blume K G; O'Donnell M R; Chauncey T; Forman S J; Deeg H J; Hu W W; Appelbaum F R; Doney K; Flowers M E; Sanders J; Leisenring W
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):39-44.
2001: Zaucha J A; Yu C; Lothrop C D; Nash R A; Sale G; Georges G; Kiem H P; Niemeyer G P; Dufresne M; Cao Q; Storb R
Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):14-24.
2000: Koc S; Leisenring W; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Blood 2000;96(12):3995-6.
2000: Mathioudakis G; Storb R; McSweeney P A; Torok-Storb B; Lansdorp P M; Brümmendorf T H; Gass M J; Bryant E M; Storek J; Flowers M E; Gooley T; Nash R A
Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients.
Blood 2000;96(12):3991-4.
2000: Storb R; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D
Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century.
Transplantation proceedings 2000;32(7):2548-9.
2000: Hägglund H G; McSweeney P A; Mathioudakis G; Bruno B; Georges G E; Gass M J; Moore P; Sale G E; Storb R; Nash R A
Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells.
Transplantation 2000;70(10):1437-42.
2000: Furlong T; Storb R; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K; Witherspoon R; Nash R A
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Bone marrow transplantation 2000;26(9):985-91.
2000: Nash R A; Antin J H; Karanes C; Fay J W; Avalos B R; Yeager A M; Przepiorka D; Davies S; Petersen F B; Bartels P; Buell D; Fitzsimmons W; Anasetti C; Storb R; Ratanatharathorn V
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Blood 2000;96(6):2062-8.
2000: Sierra J; Storer B; Hansen J A; Martin P J; Petersdorf E W; Woolfrey A; Matthews D; Sanders J E; Storb R; Appelbaum F R; Anasetti C
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience.
Bone marrow transplantation 2000;26(4):397-404.
2000: Mielcarek M; Leisenring W; Torok-Storb B; Storb R
Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.
Blood 2000;96(3):1150-6.
2000: Zang D Y; Deeg H J; Gooley T; Anderson J E; Anasetti C; Sanders J; Myerson D; Storb R; Appelbaum F
Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation.
British journal of haematology 2000;110(1):217-22.
2000: Wagner J L; Creer S A; Storb R
Dog class I gene DLA-88 histocompatibility typing by PCR-SSCP and sequencing.
Tissue antigens 2000;55(6):564-7.
2000: Little M T; Storb R
The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain.
The Journal of clinical investigation 2000;105(12):1679-81.
2000: Storek J; Storb R
T-cell reconstitution after stem-cell transplantation--by which organ:.
Lancet 2000;355(9218):1843-4.
2000: Georges G E; Storb R; Thompson J D; Yu C; Gooley T; Bruno B; Nash R A
Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
Blood 2000;95(10):3262-9.
2000: Sandmaier B M; McSweeney P; Yu C; Storb R
Nonmyeloablative transplants: preclinical and clinical results.
Seminars in oncology 2000;27(2 Suppl 5):78-81.
2000: Yu C; Linsley P; Seidel K; Sale G; Deeg H J; Nash R A; Storb R
Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model.
Transplantation 2000;69(3):450-4.
2000: Deeg H J; Shulman H M; Anderson J E; Bryant E M; Gooley T A; Slattery J T; Anasetti C; Fefer A; Storb R; Appelbaum F R
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.
Blood 2000;95(4):1188-94.
2000: Cavallaro A M; Lilleby K; Majolino I; Storb R; Appelbaum F R; Rowley S D; Bensinger W I
Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Bone marrow transplantation 2000;25(1):85-9.
2000: Wagner J L; Seidel K; Boeckh M; Storb R
De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(6):633-9.
2000: Carnevale-Schianca F; Martin P; Sullivan K; Flowers M; Gooley T; Anasetti C; Deeg J; Furlong T; McSweeney P; Storb R; Nash R A
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(6):613-20.
2000: Flowers M E; Leisenring W; Beach K; Riddell S; Radich J P; Higano C S; Rowley S D; Chauncey T R; Sanders J E; Anasetti C; Storb R; Wade J; Appelbaum F R; Martin P
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):321-6.
1999: Clift R A; Radich J; Appelbaum F R; Martin P; Flowers M E; Deeg H J; Storb R; Thomas E D
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia.
Blood 1999;94(11):3960-2.
1999: Yamaguchi M; McSweeney P A; Kimball L; Gersuk G; Hong D S; Kwok W; Storb R; Beckham C; Deeg H J
Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.
Transplantation 1999;68(8):1161-71.
1999: Storb R; Yu C; Zaucha J M; Deeg H J; Georges G; Kiem H P; Nash R A; McSweeney P A; Wagner J L
Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
Blood 1999;94(7):2523-9.
1999: Goerner M; Bruno B; McSweeney P A; Buron G; Storb R; Kiem H P
The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs.
Blood 1999;94(7):2287-92.
1999: Martin P J; Rowley S D; Anasetti C; Chauncey T R; Gooley T; Petersdorf E W; van Burik J A; Flowers M E; Storb R; Appelbaum F R; Hansen J A
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Blood 1999;94(7):2192-9.
1999: Bruno B; Nash R A; Wallace P M; Gass M J; Thompson J; Storb R; McSweeney P A
CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation.
Transplantation 1999;68(3):338-44.
1999: Matthews D C; Appelbaum F R; Eary J F; Fisher D R; Durack L D; Hui T E; Martin P J; Mitchell D; Press O W; Storb R; Bernstein I D
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.
Blood 1999;94(4):1237-47.
1999: Storb R; Yu C; Barnett T; Wagner J L; Deeg H J; Nash R A; Kiem H P; McSweeney P; Seidel K; Georges G; Zaucha J M
Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
Blood 1999;94(3):1131-6.
1999: Kiem H P; McSweeney P A; Bruno B; Goerner M; Buron G; Morris J; Storb R; Miller A D
Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector.
Gene therapy 1999;6(6):966-72.
1999: Barsoukov A A; Moore P F; Storb R; Santos E B; Sandmaier B M
The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
Transplantation 1999;67(10):1329-35.
1999: Mielcarek M; Bryant E; Loken M; Torok-Storb B; Storb R
Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation.
British journal of haematology 1999;105(2):361-5.
1999: Storb R; Yu C; Sandmaier B M; McSweeney P A; Georges G; Nash R A; Woolfrey A
Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting.
Annals of the New York Academy of Sciences 1999;872():372-5; discussion 375-6.
1999: Storb R; Yu C; Sandmaier B; McSweeney P; Georges G; Nash R; Woolfrey A
Mixed hematopoietic chimerism after hematopoietic stem cell allografts.
Transplantation proceedings 1999;31(1-2):677-8.
1999: Wagner J L; Burnett R C; Storb R
Organization of the canine major histocompatibility complex: current perspectives.
The Journal of heredity 1999;90(1):35-8.
1999: Feinstein L C; Seidel K; Jocum J; Bowden R A; Anasetti C; Deeg H J; Flowers M E; Kansu E; Martin P J; Nash R A; Storek J; Etzioni R; Applebaum F R; Hansen J A; Storb R; Sullivan K M
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):369-78.
1999: Deeg H J; Schuler U S; Shulman H; Ehrsam M; Renner U; Yu C; Storb R; Ehninger G
Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologous marrow in a canine model.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(5):316-21.
1999: McSweeney P A; Storb R
Mixed chimerism: preclinical studies and clinical applications.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(4):192-203.
1999: Storb R; Raff R F; Graham T; Appelbaum F R; Deeg H J; Schuening F G; Sale G; Seidel K
Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(3):155-61.
1998: Martin P J; Schoch G; Gooley T; Anasetti C; Deeg H J; Nash R; Sanders J; Storb R; Appelbaum F
Methods for assessment of graft-versus-host disease.
Blood 1998;92(9):3479-81.
1998: Wagner J L; Works J D; Storb R
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
Tissue antigens 1998;52(4):397-401.
1998: Stucki A; Leisenring W; Sandmaier B M; Sanders J; Anasetti C; Storb R
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Blood 1998;92(8):2742-9.
1998: Ratanatharathorn V; Nash R A; Przepiorka D; Devine S M; Klein J L; Weisdorf D; Fay J W; Nademanee A; Antin J H; Christiansen N P; van der Jagt R; Herzig R H; Litzow M R; Wolff S N; Longo W L; Petersen F B; Karanes C; Avalos B; Storb R; Buell D N; Maher R M; Fitzsimmons W E; Wingard J R
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Blood 1998;92(7):2303-14.
1998: Wagner J L; Hayes-Lattin B; Works J D; Storb R
Molecular analysis and polymorphism of the DLA-DQB genes.
Tissue antigens 1998;52(3):242-50.
1998: Georges G E; Storb R; Brunvand M W; Kiem H P; Moore P F; Malik P; Ennist D; Nash R A
Canine T cells transduced with a herpes simplex virus thymidine kinase gene: a model to study effects on engraftment and control of graft-versus-host disease.
Transplantation 1998;66(4):540-4.
1998: Clift R A; Buckner C D; Appelbaum F R; Sullivan K M; Storb R; Thomas E D
Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.
Blood 1998;92(4):1455-6.
1998: Wagner J L; Flowers M E; Longton G; Storb R; Schubert M; Sullivan K M
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation.
Bone marrow transplantation 1998;22(2):139-46.
1998: Morton A J; Gooley T; Hansen J A; Appelbaum F R; Bruemmer B; Bjerke J W; Clift R; Martin P J; Petersdorf E W; Sanders J E; Storb R; Sullivan K M; Woolfrey A; Anasetti C
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.
Blood 1998;92(2):394-401.
1998: Sullivan K M; Anasetti C; Horowitz M; Rowlings P A; Petersdorf E W; Martin P J; Clift R A; Walters M C; Gooley T; Sierra J; Anderson J E; Bjerke J; Siadak M; Flowers M E; Nash R A; Sanders J E; Appelbaum F R; Storb R; Hansen J A
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
Annals of the New York Academy of Sciences 1998;850():312-24.
1998: Storb R; Yu C; Deeg H J; Georges G; Kiem H P; Mcsweeney P A; Nash R A; Sandmaier B M; Sullivan K M; Wagner J L; Walters M C
Current and future preparative regimens for bone marrow transplantation in thalassemia.
Annals of the New York Academy of Sciences 1998;850():276-87.
1998: Deeg H J; Leisenring W; Storb R; Nims J; Flowers M E; Witherspoon R P; Sanders J; Sullivan K M
Long-term outcome after marrow transplantation for severe aplastic anemia.
Blood 1998;91(10):3637-45.
1998: Sandmaier B M; Storb R; Bennett K L; Appelbaum F R; Santos E B
Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model.
Blood 1998;91(9):3494-502.
1998: Graumann M B; DeRose S A; Ostrander E A; Storb R
Polymorphism analysis of four canine MHC class I genes.
Tissue antigens 1998;51(4 Pt 1):374-81.
1998: Hansen J A; Gooley T A; Martin P J; Appelbaum F; Chauncey T R; Clift R A; Petersdorf E W; Radich J; Sanders J E; Storb R F; Sullivan K M; Anasetti C
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
The New England journal of medicine 1998;338(14):962-8.
1998: Yu C; Seidel K; Nash R A; Deeg H J; Sandmaier B M; Barsoukov A; Santos E; Storb R
Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts.
Blood 1998;91(7):2581-7.
1998: Storb R; Raff R; Deeg H J; Graham T; Appelbaum F R; Schuening F G; Shulman H; Seidel K; Leisenring W
Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts.
International journal of radiation oncology, biology, physics 1998;40(4):961-6.
1998: McSweeney P A; Rouleau K A; Wallace P M; Bruno B; Andrews R G; Krizanac-Bengez L; Sandmaier B M; Storb R; Wayner E; Nash R A
Characterization of monoclonal antibodies that recognize canine CD34.
Blood 1998;91(6):1977-86.
1998: Martin P; Nash R; Sanders J; Leisenring W; Anasetti C; Deeg H J; Storb R; Appelbaum F
Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation.
Bone marrow transplantation 1998;21(3):273-9.
1998: Sullivan K M; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak M F; Davis C; Appelbaum F R; Buckner C D; Hansen J A; Shulman H M; Storb R; McDonald G B
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):20-6.
1997: Storek J; Gooley T; Siadak M; Bensinger W I; Maloney D G; Chauncey T R; Flowers M; Sullivan K M; Witherspoon R P; Rowley S D; Hansen J A; Storb R; Appelbaum F R
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.
Blood 1997;90(12):4705-9.
1997: Storb R
Aplastic anemia.
Journal of intravenous nursing : the official publication of the Intravenous Nurses Society 1997;20(6):317-22.
1997: Storek J; Mendelman P M; Witherspoon R P; McGregor B A; Storb R
IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(5):1253-5.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K M; Witherspoon R; Pettinger M; Bensinger W; Buckner C D; Clift R; Flowers M E; Hansen J A; Pepe M; Chauncey T; Sanders J; Thomas E D
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: Sierra J; Radich J; Hansen J A; Martin P J; Petersdorf E W; Bjerke J; Bryant E; Nash R A; Sanders J E; Storb R; Sullivan K M; Appelbaum F R; Anasetti C
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood 1997;90(4):1410-4.
1997: Yu C; Seidel K; Fitzsimmons W E; Sale G; Storb R
Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation.
Bone marrow transplantation 1997;20(2):137-41.
1997: Sierra J; Storer B; Hansen J A; Bjerke J W; Martin P J; Petersdorf E W; Appelbaum F R; Bryant E; Chauncey T R; Sale G; Sanders J E; Storb R; Sullivan K M; Anasetti C
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.
Blood 1997;89(11):4226-35.
1997: Burnett R C; DeRose S A; Wagner J L; Storb R
Molecular analysis of six dog leukocyte antigen class I sequences including three complete genes, two truncated genes and one full-length processed gene.
Tissue antigens 1997;49(5):484-95.
1997: Deeg H J; Lin D; Leisenring W; Boeckh M; Anasetti C; Appelbaum F R; Chauncey T R; Doney K; Flowers M; Martin P; Nash R; Schoch G; Sullivan K M; Witherspoon R P; Storb R
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Blood 1997;89(10):3880-7.
1997: McSweeney P A; Nash R A; Storb R; Furst D E; Gauthier J; Sullivan K M
Autologous stem cell transplantation for autoimmune diseases: issues in protocol development.
The Journal of rheumatology. Supplement 1997;48():79-84.
1997: Nash R A; McSweeney P A; Storb R; Nelson J L; Gauthier J; Furst D E; Sullivan K M
Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease.
The Journal of rheumatology. Supplement 1997;48():72-8.
1997: Storb R
Hematopoietic stem cell transplantation in nonmalignant diseases.
The Journal of rheumatology. Supplement 1997;48():30-5.
1997: Nelson J L; Torrez R; Louie F M; Choe O S; Storb R; Sullivan K M
Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation.
The Journal of rheumatology. Supplement 1997;48():23-9.
1997: Anderson J E; Gooley T A; Schoch G; Anasetti C; Bensinger W I; Clift R A; Hansen J A; Sanders J E; Storb R; Appelbaum F R
Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.
Blood 1997;89(7):2578-85.
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: Storb R; Yu C; Wagner J L; Deeg H J; Nash R A; Kiem H P; Leisenring W; Shulman H
Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Blood 1997;89(8):3048-54.
1997: Deeg H J; Seidel K; Hong D S; Yu C; Huss R; Schuening F G; Ewel C H; Storb R
In vivo radioprotective effect of AcSDKP on canine myelopoiesis.
Annals of hematology 1997;74(3):117-22.
1997: Demirer T; Buckner C D; Storer B; Lilleby K; Rowley S; Clift R; Appelbaum F R; Storb R; Bensinger W I
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):684-90.
1997: Doney K; Leisenring W; Storb R; Appelbaum F R
Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Annals of internal medicine 1997;126(2):107-15.
1996: Sandmaier B M; Storb R; Liu Y; Santos E B; Bryant E; Schuening F G; Deeg H J; Seidel K; Graham T
An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.
Transplant immunology 1996;4(4):271-4.
1996: Bensinger W I; Buckner C D; Shannon-Dorcy K; Rowley S; Appelbaum F R; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Blood 1996;88(11):4132-8.
1996: Wagner J L; Burnett R C; Works J D; Storb R
Molecular analysis of DLA-DRBB1 polymorphism.
Tissue antigens 1996;48(5):554-61.
1996: Wagner J L; Burnett R C; Storb R
Molecular analysis of the DLA DR region.
Tissue antigens 1996;48(5):549-53.
1996: Nash R A; Piñeiro L A; Storb R; Deeg H J; Fitzsimmons W E; Furlong T; Hansen J A; Gooley T; Maher R M; Martin P; McSweeney P A; Sullivan K M; Anasetti C; Fay J W
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.
Blood 1996;88(9):3634-41.
1996: Nash R A; Storb R
Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.
Current opinion in immunology 1996;8(5):674-80.
1996: Huss R; Deeg H J; Gooley T; Bryant E; Leisenring W; Clift R; Buckner C D; Martin P; Storb R; Appelbaum F R
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Bone marrow transplantation 1996;18(4):767-76.
1996: Bensinger W I; Clift R; Martin P; Appelbaum F R; Demirer T; Gooley T; Lilleby K; Rowley S; Sanders J; Storb R; Buckner C D
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.
Blood 1996;88(7):2794-800.
1996: Bensinger W I; Buckner C D; Anasetti C; Clift R; Storb R; Barnett T; Chauncey T; Shulman H; Appelbaum F R
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
1996: Wagner J L; Burnett R C; DeRose S A; Storb R
Molecular analysis and polymorphism of the DLA-DQA gene.
Tissue antigens 1996;48(3):199-204.
1996: Bensinger W I; Demirer T; Buckner C D; Appelbaum F R; Storb R; Lilleby K; Weiden P; Bluming A Z; Fefer A
Syngeneic marrow transplantation in patients with multiple myeloma.
Bone marrow transplantation 1996;18(3):527-31.
1996: Wagner J L; Burnett R C; DeRose S A; Francisco L V; Storb R; Ostrander E A
Histocompatibility testing of dog families with highly polymorphic microsatellite markers.
Transplantation 1996;62(6):876-7.
1996: McSweeney P A; Rouleau K A; Storb R; Bolles L; Wallace P M; Beauchamp M; Krizanac-Bengez L; Moore P; Sale G; Sandmaier B; de Revel T; Appelbaum F R; Nash R A
Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein.
Blood 1996;88(6):1992-2003.
1996: Kiem H P; Leisenring W; Raff R; Deeg H J; Schuening F G; Appelbaum F R; Storb R
Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation.
Blood 1996;88(5):1896-7.
1996: Martin P J; Nelson B J; Appelbaum F R; Anasetti C; Deeg H J; Hansen J A; McDonald G B; Nash R A; Sullivan K M; Witherspoon R P; Scannon P J; Friedmann N; Storb R
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.
Blood 1996;88(3):824-30.
1996: Walters M C; Patience M; Leisenring W; Eckman J R; Scott J P; Mentzer W C; Davies S C; Ohene-Frempong K; Bernaudin F; Matthews D C; Storb R; Sullivan K M
Bone marrow transplantation for sickle cell disease.
The New England journal of medicine 1996;335(6):369-76.
1996: Brunvand M W; Bensinger W I; Soll E; Weaver C H; Rowley S D; Appelbaum F R; Lilleby K; Clift R A; Gooley T A; Press O W; Fefer A; Storb R; Sanders J E; Martin P L; Chauncey T; Maziarz R T; Zuckerman N; Montgomery P; Dorn R; Weiden P L; Demirer T; Holmberg L A; Schiffman K; McSweeney P A; Buckner C D
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1996;18(1):131-41.
1996: Deeg H J; Pierpaoli W; Arrighi S; Seidel K; Graham T; Huss R; Yu C; Myerson D; Schuening F; Storb R
Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin?
Transplant immunology 1996;4(2):113-6.
1996: Schiffman K S; Bensinger W I; Appelbaum F R; Rowley S; Lilleby K; Clift R A; Weaver C H; Demirer T; Sanders J E; Petersdorf S; Gooley T; Weiden P; Zuckerman N; Montgomery P; Maziarz R; Klarnet J P; Rivkin S; Trueblood K; Storb R; Holmberg L; Buckner C D
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Bone marrow transplantation 1996;17(6):943-50.
1996: Demirer T; Buckner C D; Gooley T; Appelbaum F R; Rowley S; Chauncey T; Lilleby K; Storb R; Bensinger W I
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1996;17(6):937-41.
1996: Storek J; Witherspoon R P; Webb D; Storb R
Lack of B cells precursors in marrow transplant recipients with chronic graft-versus-host disease.
American journal of hematology 1996;52(2):82-9.
1996: Kiem H P; McDonald G B; Myerson D; Spurgeon C L; Deeg H J; Sanders J E; Doney K; Appelbaum F R; Sullivan K M; Witherspoon R P; Storb R
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):93-9.
1996: Deeg H J; Seidel K; Yu C; Nash R; Huss R; Schuening F; Storb R
Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):105-11.
1996: Walters M C; Patience M; Leisenring W; Eckman J R; Buchanan G R; Rogers Z R; Olivieri N E; Vichinsky E; Davies S C; Mentzer W C; Powars D; Scott J P; Bernaudin F; Ohene-Frempong K; Darbyshire P J; Wayne A; Roberts I A; Dinndorf P; Brandalise S; Sanders J E; Matthews D C; Appelbaum F R; Storb R; Sullivan K M
Barriers to bone marrow transplantation for sickle cell anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):100-4.
1996: Clift R A; Storb R
Marrow transplantation for CML: the Seattle experience.
Bone marrow transplantation 1996;17 Suppl 3():S1-3.
1996: Demirer T; Buckner C D; Appelbaum F R; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger W I
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
Bone marrow transplantation 1996;17(5):769-74.
1996: Bensinger W I; Rowley S D; Demirer T; Lilleby K; Schiffman K; Clift R A; Appelbaum F R; Fefer A; Barnett T; Storb R; Chauncey T; Maziarz R T; Klarnet J; McSweeney P; Holmberg L; Maloney D G; Weaver C H; Buckner C D
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1996: Yu C; Storb R; Deeg H J; Graham T C; Scheuning F G; Huss R; Seidel K; Fitzsimmons W E
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
Bone marrow transplantation 1996;17(4):649-53.
1996: Demirer T; Buckner C D; Appelbaum F R; Bensinger W I; Sanders J; Lambert K; Clift R; Fefer A; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(4):491-5.
1996: Sanders J E; Hawley J; Levy W; Gooley T; Buckner C D; Deeg H J; Doney K; Storb R; Sullivan K; Witherspoon R; Appelbaum F R
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Blood 1996;87(7):3045-52.
1996: Huss R; Hong D S; Beckham C; Storb R; Broudy V C; Deeg H J
Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiation.
Annals of hematology 1996;72(4):253-9.
1996: Anderson J E; Anasetti C; Appelbaum F R; Schoch G; Gooley T A; Hansen J A; Buckner C D; Sanders J E; Sullivan K M; Storb R
Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
British journal of haematology 1996;93(1):59-67.
1996: Sandmaier B M; Storb R; Santos E B; Krizanac-Bengez L; Lian T; McSweeney P A; Yu C; Schuening F G; Deeg H J; Graham T
Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors.
Blood 1996;87(8):3508-13.
1996: Bensinger W I; Buckner C D; Demirer T; Storb R; Appelbaum F A
Transplantation of allogeneic peripheral blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S56-7.
1996: Bensinger W I; Buckner C D; Rowley S; Demirer T; Storb R; Appelbaum F A
Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.
Bone marrow transplantation 1996;17 Suppl 2():S38-9.
1996: Bensinger W I; Buckner C D; Rowley S; Storb R; Appelbaum F R
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S19-21.
1996: Demirer T; Buckner C D; Appelbaum F R; Lambert K; Bensinger W I; Clift R; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(3):341-6.
1996: Langston A A; Sanders J E; Deeg H J; Crawford S W; Anasetti C; Sullivan K M; Flowers M E; Storb R
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.
British journal of haematology 1996;92(3):758-65.
1996: Sullivan K M; Storek J; Kopecky K J; Jocom J; Longton G; Flowers M; Siadak M; Nims J; Witherspoon R P; Anasetti C; Appelbaum F R; Bowden R A; Buckner C D; Crawford S W; Deeg H J; Hansen J A; McDonald G B; Sanders J E; Storb R
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(1):44-53.
1996: Kiem H P; Darovsky B; Von Kalle C; Goehle S; Graham T; Miller A D; Storb R; Schuening F G
Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors.
Human gene therapy 1996;7(1):89-96.
1996: Bean M A; Graham T; Appelbaum F R; Deeg H J; Schuening F; Sale G E; Leisenring W; Pepe M; Storb R
Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens.
Transplantation 1996;61(2):334-5.
1996: Wagner J L; Deeg H J; Seidel K; Anasetti C; Doney K; Sanders J; Sullivan K M; Storb R
Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.
Transplantation 1996;61(1):54-61.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T R; Clift R A; Doney K; Flowers M; Hansen J A; Martin P J; Matthews D C; Sanders J E; Shulman H; Sullivan K M; Witherspoon R P; Storb R
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1996: Deeg H J; Socié G; Schoch G; Henry-Amar M; Witherspoon R P; Devergie A; Sullivan K M; Gluckman E; Storb R
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Blood 1996;87(1):386-92.
1995: Storb R; Deeg H J; Raff R; Schuening F; Yu C; Sandmaier B M; Graham T
Prevention of graft-versus-host disease. Studies in a canine model.
Annals of the New York Academy of Sciences 1995;770():149-64.
1995: Yu C; Storb R; Mathey B; Deeg H J; Schuening F G; Graham T C; Seidel K; Burnett R; Wagner J L; Shulman H; Sandmaier B M
DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.
Blood 1995;86(11):4376-81.
1995: Nash R A; Storb R
Transplantation of hematopoietic stem cells.
Proceedings of the Association of American Physicians 1995;107(3):288-95.
1995: Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2547-55.
1995: Balduzzi A; Gooley T; Anasetti C; Sanders J E; Martin P J; Petersdorf E W; Appelbaum F R; Buckner C D; Matthews D; Storb R; Sullivan K M; Hansen J A
Unrelated donor marrow transplantation in children.
Blood 1995;86(8):3247-56.
1995: Storb R
Prevention of graft-versus-host disease after bone marrow transplantation.
Transplantation proceedings 1995;27(5):2653-6.
1995: Storb R
Bone marrow transplantation.
Transplantation proceedings 1995;27(5):2649-52.
1995: Storek J; Witherspoon R P; Storb R
T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life.
Bone marrow transplantation 1995;16(3):413-25.
1995: Burnett R C; Francisco L V; DeRose S A; Storb R; Ostrander E A
Identification and characterization of a highly polymorphic microsatellite marker within the canine MHC class I region.
Mammalian genome : official journal of the International Mammalian Genome Society 1995;6(9):684-5.
1995: Kalhs P; Schwarzinger I; Anderson G; Mori M; Clift R A; Storb R; Buckner C D; Appelbaum F R; Hansen J A; Sullivan K M
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.
Blood 1995;86(5):2028-32.
1995: Nash R A; Burstein S A; Storb R; Yang W; Abrams K; Appelbaum F R; Boone T; Deeg H J; Durack L D; Schuening F G
Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.
Blood 1995;86(5):1765-75.
1995: Yu C; Storb R; Braude I; Deeg H J; Schuening F G; Huss R; Graham T C
Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts.
Transplantation 1995;60(4):384-6.
1995: Doney K C; Storb R; Beach K; Anasetti C; Deeg H J; Hansen J A; Martin P J; Nash R A; Schubert M M; Sullivan K M
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.
Transplantation 1995;60(1):55-8.
1995: Demirer T; Petersen F B; Appelbaum F R; Barnett T A; Sanders J; Deeg H J; Storb R; Doney K; Bensinger W I; Shannon-Dorcy K
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
International journal of radiation oncology, biology, physics 1995;32(4):1103-9.
1995: Hong D S; Graham T; Ewel C; Storb R; Deeg H J
Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs.
Experimental hematology 1995;23(7):639-44.
1995: Demirer T; Rowley S; Buckner C D; Appelbaum F R; Lilleby K; Storb R; Schiffman K; Bensinger W I
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1714-9.
1995: Ehninger G; Schuler U; Renner U; Ehrsam M; Zeller K P; Blanz J; Storb R; Deeg H J
Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine model.
Blood 1995;85(11):3247-9.
1995: Demirer T; Buckner C D; Appelbaum F R; Petersen F B; Rowley S; Weaver C H; Lilleby K; Sanders J; Chauncey T; Storb R
Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Bone marrow transplantation 1995;15(6):915-22.
1995: Demirer T; Gooley T; Buckner C D; Petersen F B; Lilleby K; Rowley S; Sanders J; Storb R; Appelbaum F R; Bensinger W I
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Bone marrow transplantation 1995;15(6):907-13.
1995: Nash R A; Etzioni R; Storb R; Furlong T; Gooley T; Anasetti C; Appelbaum F R; Doney K; Martin P; Slattery J
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.
Blood 1995;85(12):3746-53.
1995: Storb R; Raff R F; Deeg H J; Graham T C; Schuening F G; Shulman H; Bryant E
DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment.
Transplantation 1995;59(10):1481-2.
1995: Nash R A; Seidel K; Storb R; Slichter S; Schuening F G; Appelbaum F R; Becker A B; Bolles L; Deeg H J; Graham T
Effects of rhIL-11 on normal dogs and after sublethal radiation.
Experimental hematology 1995;23(5):389-96.
1995: Storek J; Witherspoon R P; Luthy D; Storb R
Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cells.
Bone marrow transplantation 1995;15(5):679-84.
1995: Wagner J L; DeRose S A; Burnett R C; Storb R
Nucleotide sequence and polymorphism analysis of canine DRA cDNA clones.
Tissue antigens 1995;45(4):284-7.
1995: Kiem H P; von Kalle C; Schuening F; Storb R
Gene therapy and bone marrow transplantation.
Current opinion in oncology 1995;7(2):107-14.
1995: Bensinger W I; Weaver C H; Appelbaum F R; Rowley S; Demirer T; Sanders J; Storb R; Buckner C D
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.
Blood 1995;85(6):1655-8.
1995: Barquinero J; Kiem H P; von Kalle C; Darovsky B; Goehle S; Graham T; Seidel K; Storb R; Schuening F G
Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs.
Blood 1995;85(5):1195-201.
1995: Langenmayer I; Weaver C; Buckner C D; Lilleby K; Appelbaum F R; Longin K; Rowley S; Storb R; Singer J; Bensinger W I
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
Bone marrow transplantation 1995;15(2):241-6.
1995: Hong D S; Huss R; Beckham C; Hoy C A; Storb R; Deeg H J
Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by c-kit ligand.
Transplantation proceedings 1995;27(1):642-3.
1995: Fay J W; Nash R A; Wingard J R; Przepiorka D; Collins R H; Anasetti C; Devine S M; Piñeiro L A; Storb R F; Aro R M
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
Transplantation proceedings 1995;27(1):1374.
1995: Jakic-Razumovic J; Sale G E; Beauchamp M D; Storb R; Sandmaier B M
CD8+ activated T lymphocytes produce an in vitro skin graft-versus-host reaction in an organotypic skin culture model.
Transplantation 1995;59(1):69-78.
1995: Kalhs P; White J S; Gervassi A; Storb R; Bean M A
In vitro recall of proliferative and cytolytic responses to minor histocompatibility antigens by dendritic cell enriched canine peripheral blood mononuclear cells.
Transplantation 1995;59(1):112-8.
1995: Lynch M H; Petersen F B; Appelbaum F R; Bensinger W I; Clift R A; Storb R; Sanders J E; Hansen J A; Buckner C D
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
Bone marrow transplantation 1995;15(1):59-64.
1995: Huss R; Hong D S; Beckham C; Kimball L; Myerson D H; Storb R; Deeg H J
Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells.
Experimental hematology 1995;23(1):33-40.
1994: Sale G E; Raff R F; Storb R
Stem cell regions in filiform papillae of tongue as targets of graft-versus-host disease.
Transplantation 1994;58(11):1273-5.
1994: Huss R; Beckham C; Storb R; Deeg H J
Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
Transplantation 1994;58(12):1366-71.
1994: Weaver C H; Clift R A; Deeg H J; Storb R; Appelbaum F R; Bensinger W; Doney K; Hansen J A; Martin P O; Sanders J
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Bone marrow transplantation 1994;14(6):885-93.
1994: von Kalle C; Kiem H P; Goehle S; Darovsky B; Heimfeld S; Torok-Storb B; Storb R; Schuening F G
Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector.
Blood 1994;84(9):2890-7.
1994: Storb R; Raff R F; Appelbaum F R; Deeg H J; Graham T C; Schuening F G; Shulman H; Yu C; Bryant E; Burnett R
DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.
Blood 1994;84(10):3558-66.
1994: Yu C; Ostrander E; Bryant E; Burnett R; Storb R
Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting.
Transplantation 1994;58(6):701-6.
1994: Witherspoon R P; Deeg H J; Storb R
Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Transplantation science 1994;4(1):33-41.
1994: Raff R F; Sandmaier B M; Graham T; Loughran T P; Pettinger M; Storb R
'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
Experimental hematology 1994;22(9):893-7.
1994: Sayer H G; Longton G; Bowden R; Pepe M; Storb R
Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention.
Blood 1994;84(4):1328-32.
1994: Anasetti C; Hansen J A; Waldmann T A; Appelbaum F R; Davis J; Deeg H J; Doney K; Martin P J; Nash R; Storb R
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
Blood 1994;84(4):1320-7.
1994: Storb R; Etzioni R; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W; Bryant E; Clift R; Deeg H J; Doney K
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
1994: Storb R; Raff R F; Appelbaum F R; Deeg H J; Graham T C; Schuening F G; Sale G; Bryant E; Seidel K
Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts.
Blood 1994;83(11):3384-9.
1994: de Revel T; Appelbaum F R; Storb R; Schuening F; Nash R; Deeg J; McNiece I; Andrews R; Graham T
Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs.
Blood 1994;83(12):3795-9.
1994: Witherspoon R P; Deeg H J; Storb R
Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Transplantation 1994;57(10):1413-8.
1994: Nash R A; Schuening F G; Seidel K; Appelbaum F R; Boone T; Deeg H J; Graham T C; Hackman R; Sullivan-Pepe M; Storb R
Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1994;83(7):1963-70.
1994: Deeg H J; Beckham C; Huss R; Myerson D; Greinix H; Appelbaum F R; Graham T; Schuening F; Storb R
Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand.
Blood 1994;83(8):2352-9.
1994: Schwarzinger I; Raff R F; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum F R; Schuening F; Storb R
Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
Bone marrow transplantation 1994;13(3):303-9.
1994: Bean M A; Graham T; Appelbaum F R; Deeg H J; Schuening F; Sale G E; Storb R
Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
Transplantation 1994;57(3):423-6.
1994: Burnett R C; DeRose S A; Storb R
A simple restriction fragment-length polymorphism assay for MHC class II gene testing of dog families.
Transplantation 1994;57(2):280-2.
1994: Jakic-Razumovic J; Storb R; Sandmaier B M; Sale G E
An organotypic skin culture model in dogs. A model for transplantation immunopathology in canine systems.
Transplantation 1994;57(2):285-7.
1994: Schuening F G; Nemunaitis J; Appelbaum F R; Storb R
Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials.
Bone marrow transplantation 1994;14 Suppl 4():S74-7.
1994: Storb R
Preparative regimens for patients with leukemias and severe aplastic anemia (overview): biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center.
Bone marrow transplantation 1994;14 Suppl 4():S1-3.
1993: Storb R; Raff R F; Appelbaum F R; Deeg H J; Fitzsimmons W; Graham T C; Pepe M; Pettinger M; Sale G; van der Jagt R
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
Transplantation 1993;56(4):800-7.
1993: Weaver C H; Buckner C D; Longin K; Appelbaum F R; Rowley S; Lilleby K; Miser J; Storb R; Hansen J A; Bensinger W
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.
Blood 1993;82(7):1981-4.
1993: Dennis M B; Graham T C; Raff R F; Jones D R; Schuening F; Storb R
Implanted right atrial catheters for continuous infusion of solutions into dogs.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 1993;6(5):461-7.
1993: Doney K; Storb R; Appelbaum F R; Buckner C D; Sanders J; Singer J; Hansen J A
Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
British journal of haematology 1993;85(1):182-4.
1993: Crawford S W; Longton G; Storb R
Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia.
Bone marrow transplantation 1993;12(3):225-31.
1993: Storb R
Bone marrow transplantation for aplastic anemia.
Cell transplantation 1993;2(5):365-79.
1993: Storb R
Stem cell regulation and engraftment.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7 Suppl 2():S148-50.
1993: Storb R
Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7 Suppl 2():S135-7.
1993: Greinix H T; Storb R; Sanders J E; Deeg H J; Doney K C; Sullivan K M; Witherspoon R P
Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome).
British journal of haematology 1993;84(3):515-20.
1993: Raff R F; Severns E M; Storb R; Graham T C; Sale G; Schuening F G; Appelbaum F R
Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation.
Transplantation 1993;55(6):1244-9.
1993: Storb R; Raff R F; Graham T; Appelbaum F R; Deeg H J; Schuening F G; Shulman H; Pepe M
Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model.
International journal of radiation oncology, biology, physics 1993;26(2):275-83.
1993: Pepe M S; Longton G; Pettinger M; Mori M; Fisher L D; Storb R
Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods.
British journal of haematology 1993;83(4):602-7.
1993: Bensinger W I; Price T H; Dale D C; Appelbaum F R; Clift R; Lilleby K; Williams B; Storb R; Thomas E D; Buckner C D
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.
Blood 1993;81(7):1883-8.
1993: Schiffman K; Clift R; Appelbaum F R; Sanders J; Bensinger W; Petersen F B; Rowley S; Hill R; Martin P; Storb R
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.
Bone marrow transplantation 1993;11(3):227-32.
1993: Pene R; Appelbaum F R; Fisher L; Lilleby K; Nemunaitis J; Storb R; Buckner C D
Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
Bone marrow transplantation 1993;11(3):219-22.
1993: Raff R F; Storb R; Graham T; Deeg H J; Pepe M; Schaffer R; Sale G E; Schuening F; Appelbaum F R
What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?
Transplantation 1993;55(3):684-8.
1993: Loughran T P; Deeg H J; Storb R
Inhibition of canine NK activity by anti-CD18 monoclonal antibody, UV irradiation and cyclosporine.
Experimental hematology 1993;21(3):411-3.
1993: Ramesh N; Lau S; Palmer T D; Storb R; Osborne W R
High-level human adenosine deaminase expression in dog skin fibroblasts is not sustained following transplantation.
Human gene therapy 1993;4(1):3-7.
1993: Raff R F; Loughran T P; Graham T; Pepe M; Johnston B; Sale G E; Storb R
Splenectomy does not enhance engraftment of DLA-nonidentical marrow transplants.
Experimental hematology 1993;21(2):385-7.
1993: Schuening F G; Appelbaum F R; Deeg H J; Sullivan-Pepe M; Graham T C; Hackman R; Zsebo K M; Storb R
Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1993;81(1):20-6.
1993: Sarmiento U M; DeRose S; Sarmiento J I; Storb R
Allelic variation in the DQ subregion of the canine major histocompatibility complex: II. DQB.
Immunogenetics 1993;37(2):148-52.
1993: Schuening F; Bean M A; Deeg H J; Storb R
Prevention of graft failure in patients with aplastic anemia.
Bone marrow transplantation 1993;12 Suppl 3():S48-9.
1992: Raff R F; Storb R; Graham T; Sale G; Shulman H; Pepe M; Deeg H J; Schuening F; Appelbaum F R; Fidler J M
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.
Transplantation 1992;54(5):947-8.
1992: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Davis J; Doney K; Hill H F; Stewart P; Sullivan K M
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.
Transplantation 1992;54(5):844-51.
1992: Raff R F; Storb R; Graham T; Fidler J M; Sale G E; Johnston B; Deeg H J; Pepe M; Schuening F; Appelbaum F R
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
Transplantation 1992;54(5):813-20.
1992: Clift R A; Buckner C D; Appelbaum F R; Schoch G; Petersen F B; Bensinger W I; Sanders J; Sullivan K M; Storb R; Singer J
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1723-9.
1992: Nash R A; Pepe M S; Storb R; Longton G; Pettinger M; Anasetti C; Appelbaum F R; Bowden R A; Deeg H J; Doney K
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Blood 1992;80(7):1838-45.
1992: Greinix H T; Storb R; Bartelmez S H
Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules.
Blood 1992;80(8):1950-6.
1992: Appelbaum F R; Brown P A; Sandmaier B M; Storb R; Fisher D R; Shulman H M; Graham T C; Schuening F G; Deeg H J; Bianco J A
Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP.
Blood 1992;80(6):1608-13.
1992: Petersen F B; Buckner C D; Appelbaum F R; Sanders J E; Bensinger W I; Storb R; Deeg H J; Witherspoon R P; Sullivan K M; Clift R A
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1992;10(1):83-8.
1992: Greinix H T; Storb R; Sanders J E; Petersen F B
Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis.
Bone marrow transplantation 1992;10(1):39-44.
1992: Doney K; Pepe M; Storb R; Bryant E; Anasetti C; Appelbaum F R; Buckner C D; Sanders J; Singer J; Sullivan K
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
Blood 1992;79(10):2566-71.
1992: Kawahara K; Witherspoon R P; Storb R
Marrow transplantation for paroxysmal nocturnal hemoglobinuria.
American journal of hematology 1992;39(4):283-8.
1992: Flowers M E; Doney K C; Storb R; Deeg H J; Sanders J E; Sullivan K M; Bryant E; Witherspoon R P; Appelbaum F R; Buckner C D
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
Bone marrow transplantation 1992;9(3):167-73.
1992: Stockschlaeder M; Storb R; Pepe M; Longton G; McDonald G; Anasetti C; Appelbaum F; Doney K; Martin P; Sullivan K
A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
British journal of haematology 1992;80(1):49-54.
1992: Petersen F B; Deeg H J; Buckner C D; Appelbaum F R; Storb R; Clift R A; Sanders J E; Bensinger W I; Witherspoon R P; Sullivan K M
Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.
International journal of radiation oncology, biology, physics 1992;23(5):1027-32.
1992: Storb R
Marrow transplantation.
Current topics in microbiology and immunology 1992;177():169-86.
1992: Deeg H J; Erickson K; Storb R; Sullivan K M
Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation.
Blood cells 1992;18(1):151-61; discussion 161-2.
1992: Sarmiento U M; DeRose S; Sarmiento J I; Storb R
Allelic variation in the DQ subregion of the canine major histocompatibility complex: I. DQA.
Immunogenetics 1992;35(6):416-20.
1992: Appelbaum F R; Badger C C; Bernstein I D; Buckner C D; Deeg H J; Eary J F; Matthews D C; Press O W; Storb R; Thomas E D
Is there a better way to deliver total body irradiation?
Bone marrow transplantation 1992;10 Suppl 1():77-81.
1992: Storb R; Longton G; Anasetti C; Appelbaum F R; Beatty P; Bensinger W; Crawford S; Deeg H J; Doney K; Fefer A
Changing trends in marrow transplantation for aplastic anemia.
Bone marrow transplantation 1992;10 Suppl 1():45-52.
1991: Bean M A; Storb R; Graham T; Raff R; Sale G E; Schuening F; Appelbaum F R
Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood.
Transplantation 1991;52(6):956-60.
1991: Greinix H T; Ladiges W C; Graham T C; Maslan S; Raff R F; Sandmaier B M; Appelbaum F R; Schuening F G; Deeg H J; Storb R
Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.
Blood 1991;78(8):2131-8.
1991: Van der Jagt R H; Appelbaum F R; Petersen F B; Bigelow C L; Fisher L D; Schoch G H; Buckner C D; Sanders J E; Storb R; Sullivan K M
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
Bone marrow transplantation 1991;8(3):211-5.
1991: Storb R; Champlin R E
Bone marrow transplantation for severe aplastic anemia.
Bone marrow transplantation 1991;8(2):69-72.
1991: Kawahara K; Storb R; Sanders J; Petersen F B
Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis.
Blood 1991;78(4):1140-3.
1991: Nash R A; Schuening F; Appelbaum F; Hammond W P; Boone T; Morris C F; Slichter S J; Storb R
Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor.
Blood 1991;78(4):930-7.
1991: Nemunaitis J; Meyers J D; Buckner C D; Shannon-Dorcy K; Mori M; Shulman H; Bianco J A; Higano C S; Groves E; Storb R
Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections.
Blood 1991;78(4):907-13.
1991: Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Deeg H J; Doney K; Hansen J; Loughran T
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
1991: Buckner C D; Clift R A; Appelbaum F R; Storb R; Fefer A; Petersen F B; Sanders J E; Sullivan K; Thomas E D; Hansen J A
Effects of treatment regimens on post marrow transplant relapse.
Seminars in hematology 1991;28(3 Suppl 4):32-4.
1991: Doney K; Fisher L D; Appelbaum F R; Buckner C D; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Bone marrow transplantation 1991;7(6):453-9.
1991: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Calori E; Davis J; Doney K; Reichert T; Stewart P
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.
Bone marrow transplantation 1991;7(5):375-81.
1991: Nemunaitis J; Buckner C D; Appelbaum F R; Higano C S; Mori M; Bianco J; Epstein C; Lipani J; Hansen J; Storb R
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Blood 1991;77(9):2065-71.
1991: deGast G C; Beatty P G; Amos D; Mickelson E M; Sullivan K M; Anderson J E; Giblett E R; Appelbaum F; Storb R; Deeg H J
Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease.
Bone marrow transplantation 1991;7(4):293-5.
1991: Martin P J; Schoch G; Fisher L; Byers V; Appelbaum F R; McDonald G B; Storb R; Hansen J A
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.
Blood 1991;77(8):1821-8.
1991: Sandmaier B M; Schuening F G; Bianco J A; Rosenman S J; Bernstein I; Goehle S; Storb R; Appelbaum F R
Biochemical characterization of a unique canine myeloid antigen.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(2):125-30.
1991: Storb R; Bean M A; Appelbaum F R; Schuening F G; Graham T C; Raff R F
Treatment of marrow donor blood products with gamma-irradiation prevents transfusion-induced sensitization to DLA-identical marrow grafts.
Transplantation proceedings 1991;23(1 Pt 2):1697-8.
1991: Nemunaitis J; Singer J W; Buckner C D; Mori T; Laponi J; Hill R; Storb R; Sullivan K M; Hansen J A; Appelbaum F R
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
Bone marrow transplantation 1991;7(1):49-52.
1991: Buckner C D; Clift R A; Appelbaum F R; Storb R; Petersen F B; Sanders J E; Thomas E D; Hansen J A
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Bone marrow transplantation 1991;7 Suppl 2():6-8.
1991: Nash R A; Scherf U; Storb R
Molecular cloning of the CD3 epsilon subunit of the T-cell receptor/CD3 complex in dog.
Immunogenetics 1991;33(5-6):396-8.
1991: Stockschlaeder M A; Storb R; Osborne W R; Miller A D
L-histidinol provides effective selection of retrovirus-vector-transduced keratinocytes without impairing their proliferative potential.
Human gene therapy 1991;2(1):33-9.
1990: Loughran T P; Raff R F; Graham T C; Appelbaum F R; Schuening F G; Sale G E; Storb R
Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.
Experimental hematology 1990;18(10):1126-31.
1990: Ljungman P; Niederwieser D; Pepe M S; Longton G; Storb R; Meyers J D
Cytomegalovirus infection after marrow transplantation for aplastic anemia.
Bone marrow transplantation 1990;6(5):295-300.
1990: Anasetti C; Beatty P G; Storb R; Martin P J; Mori M; Sanders J E; Thomas E D; Hansen J A
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.
Human immunology 1990;29(2):79-91.
1990: Storb R; Pepe M; Anasetti C; Appelbaum F R; Beatty P; Doney K; Martin P; Stewart P; Sullivan K M; Witherspoon R
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Blood 1990;76(5):1037-45.
1990: Schmid I; Anasetti C; Petersen F B; Storb R
Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine.
Blut 1990;61(2-3):52-4.
1990: Sandmaier B M; Storb R; Appelbaum F R; Gallatin W M
An antibody that facilitates hematopoietic engraftment recognizes CD44.
Blood 1990;76(3):630-5.
1990: Schuening F G; Storb R; Goehle S; Graham T C; Hackman R; Mori M; Souza L M; Appelbaum F R
Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
Blood 1990;76(3):636-40.
1990: Hansen J A; Anasetti C; Beatty P G; Martin P J; Sanders J E; Storb R; Thomas E D
Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
Bone marrow transplantation 1990;6 Suppl 1():108-11.
1990: Nemunaitis J; Singer J W; Buckner C D; Durnam D; Epstein C; Hill R; Storb R; Thomas E D; Appelbaum F R
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.
Blood 1990;76(1):245-53.
1990: Storb R; Appelbaum F; Buckner C D; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Bone marrow transplantation 1990;6 Suppl 1():80-4.
1990: Storb R; Appelbaum F; Nemunaitis J; Schuening F; Singer J; Epstein C; Buckner C D; Souza L M; Thomas E D
Hematopoietic growth factors in marrow transplantation and radiation injury.
Bone marrow transplantation 1990;6 Suppl 1():116-20.
1990: Schubert M A; Sullivan K M; Schubert M M; Nims J; Hansen M; Sanders J E; O'Quigley J; Witherspoon R P; Buckner C D; Storb R
Gynecological abnormalities following allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;5(6):425-30.
1990: Loughran T P; Storb R
Treatment of aplastic anemia.
Hematology/oncology clinics of North America 1990;4(3):559-75.
1990: Flowers M E; Pepe M S; Longton G; Doney K C; Monroe D; Witherspoon R P; Sullivan K M; Storb R
Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation.
British journal of haematology 1990;74(4):492-6.
1990: Petersen F B; Appelbaum F R; Hill R; Fisher L D; Bigelow C L; Sanders J E; Sullivan K M; Bensinger W I; Witherspoon R P; Storb R
Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):638-47.
1990: Appelbaum F R; Barrall J; Storb R; Fisher L D; Schoch G; Ramberg R E; Shulman H; Anasetti C; Bearman S I; Beatty P
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.
Annals of internal medicine 1990;112(8):590-7.
1990: Storb R
Allogeneic marrow transplantation in the acute leukemias.
Current opinion in oncology 1990;2(2):250-7.
1990: Storb R; Buckner C D
Human bone marrow transplantation.
European journal of clinical investigation 1990;20(2):119-32.
1990: Ladiges W C; Storb R; Raff R F; Appelbaum F R; Sandmaier B; Schuening F; Graham T
Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
Bone marrow transplantation 1990;5(1):43-6.
1990: Sarmiento U M; Sarmiento J I; Storb R
Allelic variation in the DR subregion of the canine major histocompatibility complex.
Immunogenetics 1990;32(1):13-9.
1990: Sarmiento U M; Storb R
Nucleotide sequence of a dog class I cDNA clone.
Immunogenetics 1990;31(5-6):400-4.
1990: Sarmiento U M; Storb R
Nucleotide sequence of a dog DRB cDNA clone.
Immunogenetics 1990;31(5-6):396-9.
1990: Appelbaum F R; Nemunaitis J; Singer J W; Buckner C D; Storb R; Thomas E D
Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man.
Haematology and blood transfusion 1990;33():736-40.
1990: Storb R; Buckner C D; Clift R A; Appelbaum F R; Doney K C; Martin P; Anasetti C; Hansen J; Sanders J E; Petersen F B
Marrow grafting for acute leukemia: results and future treatment strategies.
Haematology and blood transfusion 1990;33():629-35.
1989: Petersen F B; Buckner C D; Appelbaum F R; Clift R A; Sanders J E; Bensinger W I; Storb R; Witherspoon R P; Sullivan K M; Bearman S I
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1989;4(6):617-23.
1989: Shields A F; Applebaum F R; Graham T; Deeg H J; Allalunis-Turner J; Chapman J D; Storb R
Bone marrow toxicity of total-body irradiation combined with radiosensitizers.
Radiation research 1989;120(2):364-9.
1989: Bianco J A; Sandmaier B; Brown P A; Badger C; Bernstein I; Eary J; Durack L; Schuening F; Storb R; Appelbaum F
Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization.
Experimental hematology 1989;17(9):929-34.
1989: Petersen F B; Appelbaum F R; Bigelow C L; Buckner C D; Clift R A; Sanders J E; Storb R; Sullivan K M; Weiden P L; Fefer A
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Bone marrow transplantation 1989;4(5):483-8.
1989: Witherspoon R P; Fisher L D; Schoch G; Martin P; Sullivan K M; Sanders J; Deeg H J; Doney K; Thomas D; Storb R
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
The New England journal of medicine 1989;321(12):784-9.
1989: Schuening F G; Storb R; Goehle S; Nash R; Graham T C; Appelbaum F R; Hackman R; Sandmaier B M; Urdal D L
Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1989;17(8):889-94.
1989: Sarmiento U M; Storb R F
RFLP analysis of DLA class I genes in the dog.
Tissue antigens 1989;34(3):158-63.
1989: Schuening F G; Storb R; Goehle S; Graham T C; Appelbaum F R; Hackman R; Souza L M
Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1989;74(4):1308-13.
1989: Storb R; Deeg H J; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
British journal of haematology 1989;72(4):567-72.
1989: Storb R; Raff R F; Appelbaum F R; Graham T C; Schuening F G; Sale G; Pepe M
Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts.
Blood 1989;74(3):1139-43.
1989: Schuening F G; Storb R; Stead R B; Goehle S; Nash R; Miller A D
Improved retroviral transfer of genes into canine hematopoietic progenitor cells kept in long-term marrow culture.
Blood 1989;74(1):152-5.
1989: Bensinger W; Petersen F B; Banaji M; Buckner C D; Clift R; Slichter S J; Storb R; Thomas E D
Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.
Bone marrow transplantation 1989;4(4):409-14.
1989: Appelbaum F R; Raff R F; Storb R; Deeg H J; Graham T C; Sandmaier B; Schuening F
Use of trimetrexate for the prevention of graft-versus-host disease.
Bone marrow transplantation 1989;4(4):421-4.
1989: Schuening F G; Storb R; Meyer J; Goehle S
Long-term culture of canine bone marrow cells.
Experimental hematology 1989;17(5):411-7.
1989: Appelbaum F R; Brown P; Sandmaier B; Badger C; Schuening F; Graham T; Storb R
Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation.
Blood 1989;73(8):2202-8.
1989: Storb R; Deeg H J; Pepe M; Appelbaum F; Anasetti C; Beatty P; Bensinger W; Berenson R; Buckner C D; Clift R
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Blood 1989;73(6):1729-34.
1989: Sullivan K M; Weiden P L; Storb R; Witherspoon R P; Fefer A; Fisher L; Buckner C D; Anasetti C; Appelbaum F R; Badger C
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.
Blood 1989;73(6):1720-8.
1989: Niederwieser D; Pepe M; Storb R; Witherspoon R; Longton G; Sullivan K
Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia.
Bone marrow transplantation 1989;4(2):151-6.
1989: Sullivan K M; Storb R; Buckner C D; Fefer A; Fisher L; Weiden P L; Witherspoon R P; Appelbaum F R; Banaji M; Hansen J
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.
The New England journal of medicine 1989;320(13):828-34.
1989: Beatty P G; Hansen J A; Anasetti C; Sanders J; Buckner C D; Storb R; Thomas E D
Marrow transplantation from unrelated HLA-matched volunteer donors.
Transplantation proceedings 1989;21(1 Pt 3):2993-4.
1989: Sullivan K M; Witherspoon R P; Storb R; Buckner C D; Sanders J; Thomas E D
Long-term results of allogeneic bone marrow transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2926-8.
1989: Storb R
Graft rejection and graft-versus-host disease in marrow transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2915-8.
1989: Mortimer J; Blinder M A; Schulman S; Appelbaum F R; Buckner C D; Clift R A; Sanders J E; Storb R; Thomas E D
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):50-7.
1989: Storb R
Current issues and future directions in marrow transplantation.
Haematology and blood transfusion 1989;32():37-45.
1989: Buckner C D; Sanders J E; Anasetti C; Beatty P; Hansen J A; Storb R; Clift R; Thomas E D
Donors other than HLA-identical siblings.
Progress in clinical and biological research 1989;309():383-90.
1989: Sullivan K M; Buckner C D; Sanders J E; Anasetti C; Appelbaum F R; Clark J; Doney K; Meyers J; Sale G; Storb R
Long-term complications of bone marrow transplantation.
Progress in clinical and biological research 1989;309():367-74.
1989: Buckner C D; Sanders J E; Storb R
Bone marrow transplantation.
Progress in clinical and biological research 1989;309():317-23.
1988: Agosti J M; Sprenger J D; Lum L G; Witherspoon R P; Fisher L D; Storb R; Henderson W R
Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation.
The New England journal of medicine 1988;319(25):1623-8.
1988: Martin P J; Clift R A; Fisher L D; Buckner C D; Hansen J A; Appelbaum F R; Doney K C; Sullivan K M; Witherspoon R P; Storb R
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.
Blood 1988;72(6):1978-84.
1988: Nash R; Storb R; Neiman P
Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation.
Blood 1988;72(6):2031-7.
1988: Raff R F; Severns E; Storb R; Martin P; Graham T; Sandmaier B; Schuening F; Sale G; Appelbaum F R
L-leucyl-L-leucine methyl ester treatment of canine marrow and peripheral blood cells. Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftment.
Transplantation 1988;46(5):655-60.
1988: Storb R; Raff R F; Appelbaum F R; Schuening F W; Sandmaier B M; Graham T C; Thomas E D
What radiation dose for DLA-identical canine marrow grafts?
Blood 1988;72(4):1300-4.
1988: Sarmiento U M; Storb R F
Characterization of class II alpha genes and DLA-D region allelic associations in the dog.
Tissue antigens 1988;32(4):224-34.
1988: Witherspoon R P; Sullivan K M; Lum L G; Goehle S; Atkinson M K; Ochs H D; Doney K C; Hansen J A; Sanders J E; Storb R
Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up.
Bone marrow transplantation 1988;3(5):425-35.
1988: Deeg H J; Storb R; Longton G; Graham T C; Shulman H M; Appelbaum F; Thomas E D
Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity.
International journal of radiation oncology, biology, physics 1988;15(3):647-53.
1988: Martin P J; Hansen J A; Torok-Storb B; Moretti L; Press O; Storb R; Thomas E D; Weiden P L; Vitetta E S
Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease.
Bone marrow transplantation 1988;3(5):437-44.
1988: Storb R; Raff R F; Appelbaum F R; Schuening F W; Sandmaier B M; Graham T C
The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates.
Transplantation 1988;46(2):334-6.
1988: Nemunaitis J; Singer J W; Buckner C D; Hill R; Storb R; Thomas E D; Appelbaum F R
Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.
Blood 1988;72(2):834-6.
1988: Sullivan K M; Witherspoon R P; Storb R; Deeg H J; Dahlberg S; Sanders J E; Appelbaum F R; Doney K C; Weiden P; Anasetti C
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
Blood 1988;72(2):555-61.
1988: Sullivan K M; Witherspoon R P; Storb R; Weiden P; Flournoy N; Dahlberg S; Deeg H J; Sanders J E; Doney K C; Appelbaum F R
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Blood 1988;72(2):546-54.
1988: Ladiges W C; Keast M; Appelbaum F; Storb R
Phenotypic characterization of canine lymphoma, using monoclonal antibodies and a microlymphocytotoxicity assay.
American journal of veterinary research 1988;49(6):870-2.
1988: Niederwieser D; Pepe M; Storb R; Loughran T P; Longton G
Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia.
British journal of haematology 1988;69(1):23-8.
1988: Sanders J E; Buckner C D; Amos D; Levy W; Appelbaum F R; Doney K; Storb R; Sullivan K M; Witherspoon R P; Thomas E D
Ovarian function following marrow transplantation for aplastic anemia or leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):813-8.
1988: Petersen F B; Sanders J E; Storb R; Bensinger W I; Clift R A; Buckner C D
Inadvertent administration of a greater-than-usual pre-marrow transplant dose of busulfan--report of a case.
Transplantation 1988;45(4):821-2.
1988: Riddell S; Appelbaum F R; Buckner C D; Stewart P; Clift R; Sanders J; Storb R; Sullivan K; Thomas E D
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):576-82.
1988: Deeg H J; Aprile J; Storb R; Graham T C; Hackman R; Appelbaum F R; Schuening F
Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients.
Blood 1988;71(4):1138-40.
1988: Doney K; Storb R; Buckner C D; Thomas E D
Treatment of gold-induced aplastic anaemia with immunosuppressive therapy.
British journal of haematology 1988;68(4):469-72.
1988: Appelbaum F R; Graham T; Sandmaier B; Schuening F; Storb R
Sensitivity of newly transplanted marrow to further irradiation.
Transplantation 1988;45(4):813-4.
1988: Slichter S J; Weiden P L; Kane P J; Storb R F
Approaches to preventing or reversing platelet alloimmunization using animal models.
Transfusion 1988;28(2):103-8.
1988: Stead R B; Kwok W W; Storb R; Miller A D
Canine model for gene therapy: inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors.
Blood 1988;71(3):742-7.
1988: Storb R; Deeg H J; Applebaum F R; Schuening F; Sandmaier B; Raff R F; Graham T
Failure of anti-Ia monoclonal antibody to abrogate transfusion-induced sensitization and prevent marrow graft rejection in DLA-identical canine littermates.
Transplantation 1988;45(2):505-6.
1988: Martin P J; Hansen J A; Anasetti C; Zutter M; Durnam D; Storb R; Thomas E D
Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):149-52.
1988: Storb R; Deeg H J; Fisher L; Appelbaum F; Buckner C D; Bensinger W; Clift R; Doney K; Irle C; McGuffin R
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Blood 1988;71(2):293-8.
1988: Ladiges W C; Pesando J M; Severns E; Longton G; Deeg H J; Storb R
Selective inhibition of the canine mixed lymphocyte response by HLA-DR and DP-reactive monoclonal antibodies.
Transplantation 1988;45(2):484-8.
1988: Ladiges W; Deeg H J; Pesando J; Storb R
Effect of anti-Ia monoclonal antibodies on in vitro immune responses of canine cells.
American journal of veterinary research 1988;49(2):147-51.
1988: Storb R; Raff R F; Appelbaum F R; Schuening F; Sandmaier B; Shulman H; Deeg H J; Graham T
Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Transplantation 1988;45(1):236-9.
1988: Sanders J E; Buckner C D; Clift R A; Fefer A; McGuffin R; Storb R; Appelbaum F; Bensinger W; Beatty P; Doney K
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation.
Bone marrow transplantation 1988;3(1):11-9.
1988: Schuening F; Storb R; Nash R; Stead R B; Kwok W W; Miller A D
Retroviral transfer of genes into canine hematopoietic progenitor cells.
Advances in experimental medicine and biology 1988;241():9-18.
1988: Sarmiento U M; Storb R F
Restriction fragment length polymorphism of the major histocompatibility complex of the dog.
Immunogenetics 1988;28(2):117-24.
1987: Doney K; Buckner C D; Kopecky K J; Sanders J E; Appelbaum F R; Clift R; Sullivan K; Witherspoon R; Storb R; Thomas E D
Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.
Bone marrow transplantation 1987;2(4):355-63.
1987: Storb R; Deeg H J; Appelbaum F R; Schuening F W; Raff R F; Graham T C
The biology of graft rejection in a canine model of marrow transplantation.
Transplantation proceedings 1987;19(6 Suppl 7):18-22.
1987: Appelbaum F R; Barrall J; Storb R; Ramberg R; Doney K; Sale G E; Thomas E D
Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia.
Experimental hematology 1987;15(11):1134-9.
1987: Deeg H J; Atkinson K; Weiden P W; Storb R
Mechanisms of tolerance in canine radiation chimeras.
Transplantation proceedings 1987;19(6 Suppl 7):75-81.
1987: Sale G E; Rajantie J; Doney K; Appelbaum F R; Storb R; Thomas E D
Does histologic grading of inflammation in bone marrow predict the response of aplastic anaemia patients to antithymocyte globulin therapy?
British journal of haematology 1987;67(3):261-6.
1987: Schuening F; Storb R; Goehle S; Meyer J; Graham T C; Deeg H J; Appelbaum F R; Sale G E; Graf L; Loughran T P
Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation.
Transplantation 1987;44(5):607-13.
1987: Deeg H J; Raff R F; Severns E; Szer J; Storb R
Two monoclonal antibodies recognizing subpopulations of canine T lymphocytes with or without suppressor/cytotoxic functions.
Methods and findings in experimental and clinical pharmacology 1987;9(11):755-9.
1987: Deeg H J; Severns E; Raff R F; Sale G E; Storb R
Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
Transplantation 1987;44(5):621-32.
1987: Deeg H J; Ladiges W C; Aprile J; Schuening F; Raff R F; Storb R
Monoclonal antibodies to canine differentiation antigens.
Methods and findings in experimental and clinical pharmacology 1987;9(11):749-53.
1987: Clift R A; Buckner C D; Thomas E D; Kopecky K J; Appelbaum F R; Tallman M; Storb R; Sanders J; Sullivan K; Banaji M
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.
Bone marrow transplantation 1987;2(3):243-58.
1987: Witherspoon R P; Navari R; Storb R; Sullivan K M; Doney K; Beatty P; Lum L G; Thomas E D
Treatment of marrow graft recipients with thymopentin.
Bone marrow transplantation 1987;1(4):365-71.
1987: Kanfer E J; Buckner C D; Fefer A; Storb R; Appelbaum F R; Hill R S; Amos D; Doney K C; Clift R A; Shulman H M
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Bone marrow transplantation 1987;1(4):339-46.
1987: Doney K; Storb R; Buckner C D; McGuffin R; Witherspoon R; Deeg H J; Appelbaum F R; Sullivan K M; Thomas E D
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Experimental hematology 1987;15(3):239-42.
1987: Klingemann H G; Tsoi M S; Storb R
Fibronectin restores defective in vitro proliferation of lymphocytes from patients after marrow grafting.
Transplantation proceedings 1987;19(1 Pt 3):2646-7.
1987: Raff R F; Loughran T P; Deeg H J; Aprile J A; Graham T C; Sale G E; Storb R
Role of radiation-resistant large granular lymphocytes in the rejection of unrelated DLA-nonidentical marrow grafts in dogs.
Transplantation proceedings 1987;19(1 Pt 3):2718-20.
1987: Deeg H J; Aprile J; Severns E; Rajantie J; Schmidt E; Raff R F; Green K E; Storb R
Phenotypic and functional alterations of recipient lymphocytes after transfusion of UV-irradiated and normal blood--implications for marrow transplantation.
Transplantation proceedings 1987;19(1 Pt 3):2709-14.
1987: Kanfer E J; Petersen F B; Buckner C D; Stewart P; Storb R; Hill R S; Appelbaum F R; Clift R A; Doney K C; Shulman H M
Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.
Cancer treatment reports 1987;71(1):101-2.
1987: Fefer A; Sullivan K M; Weiden P; Buckner C D; Schoch G; Storb R; Thomas E D
Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.
Progress in clinical and biological research 1987;244():401-8.
1987: Sullivan K M; Fefer A; Witherspoon R; Storb R; Buckner C D; Weiden P; Schoch G; Thomas E D
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.
Progress in clinical and biological research 1987;244():391-9.
1987: Ladiges W C; Raff R F; Storb R
A DLA-associated polymorphic cell surface determinant defined by the murine monoclonal antibody W3G10.
Animal genetics 1987;18(2):149-58.
1986: Storb R; Kolb H J; Deeg H J; Weiden P L; Appelbaum F; Graham T C; Thomas E D
Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.
Bone marrow transplantation 1986;1(2):167-77.
1986: Deeg H J; Sullivan K M; Buckner C D; Storb R; Appelbaum F R; Clift R A; Doney K; Sanders J E; Witherspoon R P; Thomas E D
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation.
Bone marrow transplantation 1986;1(2):151-7.
1986: Raff R F; Deeg H J; Loughran T P; Graham T C; Aprile J A; Sale G E; Storb R
Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors.
Blood 1986;68(4):861-8.
1986: Klingemann H G; Deeg H J; Self S; Thomas E D; Storb R
Is race a risk factor for allogeneic marrow transplantation?
Bone marrow transplantation 1986;1(1):87-94.
1986: Bolger G B; Sullivan K M; Storb R; Witherspoon R P; Weiden P L; Stewart P; Sanders J; Meyers J D; Martin P J; Doney K C
Second marrow infusion for poor graft function after allogeneic marrow transplantation.
Bone marrow transplantation 1986;1(1):21-30.
1986: Hill R S; Petersen F B; Storb R; Appelbaum F R; Doney K; Dahlberg S; Ramberg R; Thomas E D
Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
Blood 1986;67(3):811-6.
1986: Deeg H J; Aprile J; Graham T C; Appelbaum F R; Storb R
Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs.
Blood 1986;67(2):537-9.
1985: Storb R; Deeg H J; Thomas E D; Appelbaum F R; Buckner C D; Cheever M A; Clift R A; Doney K C; Flournoy N; Kennedy M S
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Blood 1985;66(3):698-702.
1985: Stewart P; Buckner C D; Bensinger W; Appelbaum F; Fefer A; Clift R; Storb R; Sanders J; Meyers J; Hill R
Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission.
Experimental hematology 1985;13(4):267-72.
1985: Szer J; Deeg H J; Severns E; Storb R
DLA-D-specific suppressor cells characterized by monoclonal antibodies.
Transplantation 1985;39(2):187-92.
1985: Brkic S; Tsoi M S; Mori T; Lachman L; Gillis S; Thomas E D; Storb R
Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease.
Transplantation 1985;39(1):30-5.
1984: Tsoi M S; Mori T; Brkic S; Dobbs S; Gillis S; Santos E; Thomas E D; Storb R
Ineffective cellular interaction and interleukin 2 deficiency causing T cell defects in human allogeneic marrow recipients early after grafting and in those with chronic graft-versus-host disease.
Transplantation proceedings 1984;16(6):1470-2.
1984: Schubert M M; Sullivan K M; Morton T H; Izutsu K T; Peterson D E; Flournoy N; Truelove E L; Sale G E; Buckner C D; Storb R
Oral manifestations of chronic graft-v-host disease.
Archives of internal medicine 1984;144(8):1591-5.
1984: Tsoi M S; Dobbs S; Brkic S; Ramberg R; Thomas E D; Storb R
Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease.
Transplantation 1984;37(6):556-61.
1984: Ladiges W C; Durkopp N; Urban C; Wulff J C; Storb R
Monoclonal antibodies to canine cell surface antigens: a comparison of screening assays.
Hybridoma 1984;3(4):387-90.
1983: Wulff J C; Springmeyer S C; Deeg H J; Storb R
Canine bronchoalveolar cells: antigen-presenting macrophages are Ia-positive, lymphocytes are of non-B lineage.
Blut 1983;47(5):263-70.
1983: Mori T; Tsoi M S; Dobbs S; Thomas E D; Storb R
Impaired autologous and allogeneic mixed lymphocyte reaction in human marrow transplant recipients.
Experimental hematology 1983;11(5):425-34.
1983: Urban C; Wulff J C; Deeg H J; Raff R F; Durkopp N; Storb R
Analysis of alloreactive and cytotoxic canine lymphocytes and their precursors with murine monoclonal antibodies.
Transplantation 1983;35(5):469-73.
1982: Wulff J C; Tsoi M S; Aprile J; Deeg H J; Durkopp N; Storb R
Stimulation of canine lymphocyte subpopulations separated nonlytically by monoclonal anti-T and polyclonal anti-B cell antibodies.
Blut 1982;45(5):309-16.
1982: Tsoi M S; Aprile J; Dobbs S; Goehle S; Storb R
Enrichment (and depletion) of human suppressor cells with monoclonal antibodies and immunoglobulin-coated plates.
Journal of immunological methods 1982;53(3):293-305.
1982: Wulff J C; Durkopp N; Aprile J; Tsoi M S; Springmeyer S C; Deeg H J; Storb R
Two monoclonal antibodies (DLy-1 and DLy-6) directed against canine lymphocytes.
Experimental hematology 1982;10(7):609-19.
1982: Atkinson K; Shulman H M; Deeg H J; Weiden P L; Graham T C; Thomas E D; Storb R
Acute and chronic graft-versus-host disease in dogs given hemopoietic grafts from DLA-nonidentical littermates. Two distinct syndromes.
The American journal of pathology 1982;108(2):196-205.
1982: Thomas E D; Clift R A; Hersman J; Sanders J E; Stewart P; Buckner C D; Fefer A; McGuffin R; Smith J W; Storb R
Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation.
International journal of radiation oncology, biology, physics 1982;8(5):817-21.
1982: Atkinson K; Storb R; Ochs H D; Goehle S; Sullivan K M; Witherspoon R P; Lum L G; Tsoi M S; Sanders J E; Parr M; Stewart P; Thomas E D
Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans.
Transplantation 1982;33(2):168-73.
1982: Deeg H J; Wulff J C; DeRose S; Sale G E; Braun M; Brown M A; Springmeyer S C; Martin P J; Storb R
Unusual distribution of Ia-like antigens on canine lymphocytes.
Immunogenetics 1982;16(5):445-57.
1982: Clift R A; Buckner C D; Thomas E D; Sanders J E; Stewart P S; McGuffin R; Hersman J; Sullivan K M; Sale G E; Storb R
Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation.
Leukemia research 1982;6(3):409-12.
1982: Clift R A; Buckner C D; Thomas E D; Sanders J E; Stewart P S; Sullivan K M; McGuffin R; Hersman J; Sale G E; Storb R
Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse.
Leukemia research 1982;6(3):401-7.
1981: Tsoi M S; Storb R; Dobbs S; Thomas E D
Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation.
Nature 1981;292(5821):355-7.
1981: Tsoi M S; Storb R; Dobbs S; Santos E; Thomas E D
Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients: implications for the mechanisms of graft-host tolerance and chronic graft-versus-host disease.
Transplantation proceedings 1981;13(1 Pt 1):237-40.
1980: Tsoi M S; Storb R; Dobbs S; Medill L; Thomas E D
Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(5):2258-62.
1980: Weiden P L; Giblett E R; Anderson J E; Storb R
Esterase D: polymorphic red blood cell enzyme in the dog.
Transplantation 1980;30(3):230-1.
1980: Atkinson K; Deeg H J; Storb R; Weiden P L; Gerhard-Miller L; Torok-Storb B J; Seigneuret M; Thomas E D
Canine lymphocyte subpopulations.
Experimental hematology 1980;8(7):821-9.
1980: Atkinson K; Storb R; Weiden P L; Deeg H J; Gerhard-Miller L; Thomas E D
In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(4):1808-14.
1980: Deeg H J; Storb R; Gerhard-Miller L; Shulman H M; Weiden P L; Thomas E D
Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance.
Transplantation 1980;29(3):230-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Rainer Storb

Research Profile (preview)

Procedures

Disorders

Living Beings

Chemicals & Drugs

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Rainer Storb (preview)

All Publications